| Aug 3, 2026 | +29.45% | Q2 FY2026 | Read transcript briefingQuarter in one view- Revenue $1.935B, +93% y/y, +19% q/q — highest growth rate ever, twelfth consecutive acceleration (+85% → +93%); ~7.5% above the $1.797–1.801B guide high end. Sequential growth reaccelerated (+19% vs +16% prior quarter) against a guide that had implied deceleration to +10%.
- U.S. revenue $1.573B, +115% y/y, +23% q/q — now 81% of revenue (from 79%). U.S. commercial $764M, +149% y/y, +28% q/q (accelerated from +133%/+143% ex-transition). U.S. government $809M, +90% y/y, +18% q/q (from +84%).
- Rule of 40 at 155 (from 145, +10pts) — twelfth consecutive expansion. Adjusted op margin 62% (from 60%); AOI $1.194B. GAAP net income $1.062B (55% margin). GAAP EPS $0.41 = adjusted EPS $0.41 — last quarter's inversion resolved, but SpaceX unrealized gains contributed +$0.03 to GAAP EPS and +$0.02 to adjusted EPS.
- Largest-ever FY guide raise, again: FY2026 revenue to $8.15–8.158B (+82% midpoint, from +71%) — an 11-point raise one quarter after a 10-point raise. U.S. commercial raised to >$3.424B (≥134%, from ≥120%); AOI to $4.889–4.897B; FCF to $4.5–4.7B. Q3 2026: revenue $2.16–2.164B (+12% q/q implied), AOI $1.292–1.296B (~60% margin).
- Headline items: NDR 157% (+700bps); U.S. commercial TCV $2.132B, +153% y/y, +81% q/q — a violent reacceleration from +45%; deal-count disclosure restored (220 ≥$1M, 98 ≥$5M, 73 ≥$10M, all records); sovereign-AI/post-training narrative (Nemotron Ultra claim, NVIDIA partnership); first Maven program of record; SBC disclosed at $265M after last quarter's inaudible figure.
What management is focused on- "Sovereign AI" is the new master narrative, superseding but incorporating the no-slop zone: enterprises must own their data, logic, actions, security — and now their model weights. Taylor frames the alternative as "token meters spinning endlessly just to get slop," breaking budgets and transferring trade secrets into frontier models' training data. Karp escalates: unprotected frontier-model interaction is "colonization" of the enterprise.
- Post-training as the new product frontier: Sankar claims vanilla Nemotron Ultra, within 24 hours in Palantir's stack, beat frontier models on 5 production tasks — "benchmaxing has ended; the new era is benchmaking" (customer-specific benchmarks directing post-training pipelines). Karp disclosed an NVIDIA partnership and entry into classified fine-tuning: "the models fine-tuned by us in our enterprise on an NVIDIA stack outperform frontier models. And you own the weights."
- FDE tradecraft as the moat, sharpened: a "major Silicon Valley tech company" bake-off — a frontier lab plus its deployment team vs AIP plus FDEs on a ticketing problem; the lab "failed to deliver anything of value," Palantir's agent swarms converted to a $10M ACV contract. "Only Palantir has FDEs. Everyone else has sparkling sales engineers."
- Model-portability as a sovereignty feature: answering Luria, Karp confirmed a product already deployed across the U.S. government allowing customers to swap models when one is pulled or degraded — positioned against lab lock-in ("heads I win, tails I win").
- Karp's 18-month growth mandate: "I am driving the business to grow at a rate equal or above to what we have in U.S. commercial [+149%] for the next 18 months" — an extraordinary informal commitment, well above the +82% FY guide, with partner-ecosystem scaling ("partners doesn't mean a vassal… they can occasionally compete against us") as the mechanism.
- Demand-side education at scale: the sovereign boot camp drew uninvited CEOs and operational leads; Karp attributes part of NDR strength to legacy Foundry-only customers now migrating across the stack. The addressable market framing expanded again: "from a small portion of the market… to like a large part of the U.S. GDP."
- American Tech Fellowship / Builder Summit: 1,000+ ATF grads; factory-floor AI stories (submarine-parts production planning 30–40 days → <1 day) used to counter the AI-jobs critique and reinforce the blue-collar alignment theme.
Key numbers and quarter mechanics- Segments: commercial $945M (+110% y/y, +22% q/q); government $990M (+79% y/y, +15% q/q). U.S. commercial $764M (+149%, +28% q/q); international commercial $182M (+26% y/y, +2% q/q — flat y/y rate, sequential growth slowed from +5%); U.S. government $809M (+90%); international government $181M (+42% y/y, +5% q/q — decelerated from +51%).
- Customers: U.S. commercial 653, +35% y/y, +6% q/q (from 615; y/y decelerated from +42% — density-over-volume continues). Total customer count not given on the call. Top-20 customers $124M TTM each, +67% y/y (from +55% — eighth consecutive acceleration).
- Bookings: total TCV $3.4B, +49% y/y (+129% dollar-weighted duration) — up from $2.4B. Commercial TCV $2.337B, +118% y/y. U.S. commercial TCV $2.132B, +153% y/y, +81% q/q — nearly $800M above the prior best quarter; the three-quarter deceleration streak (+342% → +67% → +45%) broke decisively. TTM U.S. commercial TCV $5.964B, +117% (from +115%). Deal counts restored after one absent quarter: 220 ≥$1M, 98 ≥$5M, 73 ≥$10M — records.
- Named conversions: multinational tech company expanded from one operating company (Q4 2025 start) to a 3-year ~$370M deal; global asset manager Q1 start → 3-year $35M across 4 verticals; global software/services company signed $15M 5-month initial deal after a May agent camp; nonprofit health system pilot (end-2025) → 3-year $37M.
- Forward metrics: RDV $13.1B, +83% y/y, +11% q/q (y/y decelerated from +98% — second straight deceleration despite the bookings surge; mix/duration effect worth probing). RPO $4.9B, +103% y/y, +10% q/q (decelerated from +134%). U.S. commercial RDV +124% y/y, +27% q/q (reaccelerated from +112%). NDR 157%, +700bps — Karp says it will "become even more positive" as older Foundry-only customers migrate up-stack.
- Margins: adjusted gross margin 86% (from 88%) — decline attributed to assuming cloud hosting costs for one government customer; management frames it as enabling faster time-to-value and workflow expansion. Adjusted op margin 62% (from 60%). Adjusted OpEx $741M, +14% q/q, +37% y/y (from +32% — expense growth reaccelerating; significant Q3 ramp flagged for new-hire seasonality and product/marketing initiatives).
- GAAP: GAAP op income $912M (47%); GAAP net income $1.062B (55%). GAAP EPS $0.41 = adjusted EPS $0.41 — but SpaceX unrealized gains added $0.03 GAAP / $0.02 adjusted; ex-SpaceX, adjusted EPS would exceed GAAP. SBC $265M (disclosed cleanly after last quarter's inaudible figure); equity taxes $17M.
- Cash: CFO $1.216B (63%), adjusted FCF $1.22B (63%, +115% y/y) — FCF > CFO quirk persists, still unexplained. Cash/T-bills $9.2B (from $8.0B). No buyback mention.
- Strategic contracts: ~$400K (0.02% of revenue); guided <$500K per remaining quarter.
- Guidance math: Q3 guide implies +12% q/q vs Q2's +19% actual — sequential deceleration guided again, but Q2's guide (+10%) was beaten by 9 points of sequential growth. FY +82% against Q2's +93% still embeds deceleration, though the cushion is narrowing as raises compound.
Product and launch scorecard- AIP (~4 years): validation now includes Kirkland & Ellis ("new operating model for legal services… impossible without the Ontology"), the $10M ACV bake-off win against a frontier lab, and the conversion cohort above. Still missing: pricing model, paid-conversion rates, AIP revenue attribution — now fourteen quarters.
- Sovereign AI stack / post-training (new leg): fine-tuning and RL inside the customer security boundary, weights owned by the customer; Nemotron Ultra claim (5 production tasks beating frontier, no post-training); NVIDIA partnership disclosed by Karp with no scope, economics, or timing; classified-space fine-tuning "already entering." No revenue framing, no customer count, no availability detail.
- Model-switching: confirmed as an existing deployed product across the U.S. government (first explicit confirmation) — a direct answer to model-pull risk; no commercial adoption metrics.
- Maven: first program of record launched on the Maven platform (a government program choosing Maven as its operating platform — a structural step beyond usage); 25,000+ builders across services, civilians, contractors, companies. DoW TTM revenue framed as <25bps of the Pentagon budget — a headroom argument. Still no revenue run-rate or ceiling.
- Agent engine SDK: referenced within the AIP layer stack ("agent SDKs, agent orchestration with telemetry and observability, evals") but no availability, pricing, or adoption update — the monetization question from last quarter unanswered.
- ShipOS: not mentioned — first silent quarter after two quarters of escalating metrics; the 200-hrs→15-sec BOM story was replaced by the ATF submarine-parts anecdote (30–40 days → <1 day planning, at "Talbot").
- USDA: not mentioned — no minimums, phasing, or first revenue after last quarter's $300M award.
- Warp Speed: not mentioned by name; defense-industrial-base demand folded into the ATF/manufacturing narrative.
- Apollo / zero-days: not mentioned — last quarter's "thousands of zero days" claim and next-gen Apollo got no follow-up.
- Silent again: Army Vantage (third straight quarter), TITAN (fifth), FedStart (sixth), NHS/U.K., OSDK metric, Gotham suite.
Sell-side read-through- Format loosened slightly: Ives (Wedbush) and Perez Mora (BofA) as usual, plus a third live questioner — Gil Luria (D.A. Davidson) — the first expansion of the questioner roster in at least nine quarters. Still zero adversarial questions; the call opened with a production glitch ("Where is the prompt?") before Ives recovered.
- Ives's boot-camp question produced the quarter's most strategically useful answer: Karp's disclosure that legacy Foundry-only customers are re-engaging and migrating up-stack (an NDR tailwind claim), the partner-ecosystem scaling plan, and the 18-month ≥149%-growth internal mandate — a commitment that will be tracked against every future guide.
- Perez Mora's question (why did Palantir see sovereignty early?) was soft; Sankar's answer added one substantive point — the market's realization that reasoning traces, metadata, and usage exhaust are "probably more valuable than just the data," and customers lack mechanisms to control them without owning weights.
- Luria's model-pull question was the closest to a probing question and produced a concrete disclosure: the model-switching product exists and is deployed across the USG. Notably, last quarter's unanswered CR/budget-dependency question was not re-asked by anyone.
- Unchallenged again: AIP monetization (fourteen quarters), FCF > CFO, ShipOS revenue vs $448M ceiling, USDA minimums/phasing, Maven revenue, RDV y/y deceleration (+83%) amid the bookings surge, gross-margin decline mechanics (size, duration, margin recovery path of the cloud-hosting assumption), the NVIDIA partnership's economics, the Nemotron claim's evidentiary basis, and Karp's 18-month growth mandate vs the +82% guide.
Management credibility- Beat-and-raise streak extends to fourteen quarters: ~7.5% above the Q2 high end, FY guide raised 11 points one quarter after a 10-point raise — "largest ever full year revenue guidance raise" for the second consecutive quarter. The prior quarter's most aggressive claim (FY +71%) was raised to +82%.
- Delivered on the prior watchlist's central items: Q2 vs guide ✓ (beat with 62% adjusted op margin); sequential deceleration ✓ reversed (+19% vs +10% implied); U.S. commercial TCV ✓ decisively ($2.132B, +153% — the deceleration thesis broke); U.S. commercial RDV ✓ (+124%, reaccelerated); NDR ✓ (157%); U.S. government ✓ (+90%); SBC ✓ disclosed ($265M); deal counts ✓ restored; GAAP/adjusted EPS inversion ✓ resolved (though via SpaceX gains); Maven ✓ (first program of record, builder count).
- Guidance quality: the FY guide still embeds deceleration (+82% vs +93% print), and Q3's +12% q/q guide is conservative against Q2's +19% — the cushion-and-raise pattern is intact and now predictable.
- Debits: RDV y/y growth decelerated again (+98% → +83%) and went unaddressed — the one forward metric that didn't inflect; gross margin fell 2pts on an undisclosed-size hosting arrangement; FCF > CFO unexplained for the fourteenth-plus quarter; Karp's 18-month ≥149% growth mandate is unauditable rhetoric that invites a credibility test if growth merely matches the +82% guide; the Nemotron "beat frontier in 24 hours" claim is anecdotal (5 tasks, no benchmarks named, no third-party verification).
- Consistency check: U.S. commercial TCV +153%, RDV +124%, NDR 157%, top-20 +67%, and the named conversion cohort ($370M, $37M, $35M, $15M deals) mutually corroborate the demand surge. The prior quarter's bear-case centerpiece (bookings deceleration) is now empirically weaker; the residual tension is RDV's y/y deceleration and international stagnation.
What changed versus the prior quarter- Growth: total +85% → +93%; U.S. +104% → +115%; U.S. commercial +133%/+143% ex-items → +149% (no adjustment needed this quarter — the transition has lapped or been absorbed); U.S. government +84% → +90%; international commercial +26% → +26% (stalled, +2% q/q); international government +51% → +42% (decelerated).
- Bookings: TCV $2.4B → $3.4B (+61% → +49% y/y headline, but +129% duration-weighted); U.S. commercial TCV $1.2B → $2.132B (+45% → +153% y/y — the quarter's defining inflection); RDV +98% → +83% y/y (decelerated); RPO +134% → +103% y/y (decelerated); U.S. commercial RDV +112% → +124% (reaccelerated); NDR 150% → 157%.
- Margins: adjusted op margin 60% → 62%; adjusted gross 88% → 86% (cloud-hosting assumption); GAAP net margin 53% → 55%; Rule of 40 145 → 155. OpEx +32% → +37% y/y — investment accelerating into the raise.
- Guidance: FY2026 revenue +71% → +82% midpoint; U.S. commercial ≥120% → ≥134%; AOI $4.44–4.452B → $4.889–4.897B; FCF $4.2–4.4B → $4.5–4.7B. Q3 implies +12% q/q vs Q2's +19% actual.
- Narrative: center of gravity moved from anti-slop governance to sovereign AI — owned weights, post-training, benchmaking, model portability, NVIDIA partnership. The commercial→government transition adjustment disappeared from disclosure. Europe rhetoric softened into a values justification ("we support clandestine institutions… not in our economic interest") rather than last quarter's dismissal.
- Watchlist resolution vs prior packet: Q2 vs guide ✓; FY guide raised ✓; U.S. commercial TCV/RDV ✓ inflected; NDR ✓; SBC ✓ ($265M); EPS inversion ✓ resolved (SpaceX-driven); deal counts ✓ restored; Maven ✓ partially (platform milestone; revenue ✗); ShipOS ✗ (silent); USDA ✗ (silent); agent SDK pricing ✗; Apollo/zero-days ✗ (silent); CR dependency ✗ (not asked); international ✗ (commercial flat, government decelerated); FCF vs CFO ✗; Army Vantage ✗ (third); TITAN ✗ (fifth); FedStart ✗ (sixth); buyback ✗; AIP monetization ✗ (fourteenth).
Bull case- The bear case's strongest leg just broke: U.S. commercial TCV reaccelerated from +45% to +153% y/y on an $800M-above-record quarter, with U.S. commercial RDV reaccelerating to +124% and NDR at 157% — bookings, backlog, and retention now all point the same direction as revenue for the first time in four quarters.
- Acceleration is twelve quarters deep and steepening at scale: +93% on a $1.9B quarter, U.S. at +115%, U.S. commercial at +149% with +28% sequential — and the FY guide has been raised 21 points in two quarters (+61% → +82%) while still embedding deceleration from the current run rate.
- The conversion engine is producing named, dated, sized evidence: Q4-start → $370M/3-year expansion; Q1-start → $35M/3-year; agent camp → $15M in weeks; pilot → $37M/3-year. Land-and-expand is compressing to single quarters.
- Sovereign AI opens a new TAM layer with a hardware partner: post-training/owned-weights positions Palantir between enterprises and the labs, the NVIDIA partnership adds compute-stack credibility, and the Nemotron claim — if even directionally true — undercuts the frontier-model necessity assumption that underpins lab pricing.
- Maven crossed a structural threshold: first program of record choosing Maven as its operating platform, 25,000 builders, and DoW revenue framed at <25bps of the Pentagon budget — platform status plus quantified headroom.
- Operating leverage at new extremes: 62% adjusted op margin, 55% GAAP net margin, Rule of 40 155, $1.22B FCF at 63% margin, $9.2B cash — while OpEx grows 37% and management warns of further Q3 investment, i.e., margins are expanding through an investment ramp.
Bear case- RDV y/y growth decelerated again (+105% → +98% → +83%) even in a record bookings quarter, and RPO decelerated to +103% — duration-weighted TCV (+129%) vs headline (+49%) implies mix shifting shorter; the backlog's growth rate is not confirming the revenue trajectory, and no one asked why.
- Guidance still embeds deceleration: Q3 +12% q/q after +19%, FY +82% against a +93% print. The beat-and-raise machine now requires ~$6.2B of second-half revenue; each raise compresses the cushion, and Karp's 18-month ≥149% mandate sets an informal bar the formal guide doesn't support.
- International is dead weight: commercial +26% y/y but only +2% q/q (stalled at ~$182M), government decelerated to +42% — 19% of revenue is growing at a fraction of the U.S. rate with no articulated fix, and U.S. concentration rose to 81%.
- Gross margin slipped 2pts on a single customer's cloud-hosting arrangement — undisclosed in size or duration, with only a qualitative recovery argument; a reminder that government mix can move margins at this scale.
- EPS quality: GAAP = adjusted at $0.41 only because SpaceX unrealized gains added $0.03/$0.02; ex-SpaceX the marks, not operations, closed the gap. FCF > CFO remains unexplained for the fourteenth-plus quarter.
- The product pipeline went quiet: ShipOS, USDA, Warp Speed, Apollo/zero-days all disappeared one quarter after being featured — a pattern of narrative rotation without revenue follow-through. AIP monetization is absent for the fourteenth quarter. The Q&A remains structurally incapable of testing any of this (three friendly questioners, zero follow-ups on risk).
Next-quarter watchlist- Q3 2026 vs $2.16–2.164B revenue (+12% q/q implied) and $1.292–1.296B AOI (~60% margin): does sequential growth hold above the guide again, and does the FY +82% guide get raised a third time? Track against Karp's 18-month ≥149% U.S.-commercial-rate mandate — the first checkpoint on an informal commitment.
- U.S. commercial: growth vs the +149% print; TCV against $2.132B (is +153% repeatable or a mega-deal quarter?); RDV from +124%; progress toward >$3.424B / ≥134% FY guide; customer adds from 653 with y/y growth decelerating (+42% → +35%); NDR sustainability at 157% as Karp's Foundry-migration tailwind claim seasons in.
- Total RDV: whether the +83% y/y deceleration reverses or confirms a duration/mix shift; duration-weighted vs headline TCV spread; RPO trajectory from +103%.
- Gross margin: size, duration, and recovery path of the government cloud-hosting arrangement; whether 86% is the new base or a one-quarter dip.
- Sovereign AI / post-training: first revenue, customer, or pricing evidence for fine-tuning/owned-weights; NVIDIA partnership scope and economics; any third-party substantiation of the Nemotron-beats-frontier claim; whether "benchmaking" becomes a monetizable tier — the most credible path yet to answering the fourteen-quarter AIP monetization question.
- Maven: revenue or ceiling disclosure against the first program of record; builder-count trajectory from 25,000; whether the <25bps-of-Pentagon-budget framing converts to named program expansions.
- ShipOS, USDA, Warp Speed, Apollo: any reappearance with dollars after a silent quarter — ShipOS vs the $448M ceiling, USDA minimums/phasing/first revenue, evidence for the zero-day claim.
- U.S. government: sustainability of +90%; CR/FY2026 appropriation exposure — still never quantified on any call.
- International: whether commercial's +2% q/q stall breaks; government deceleration from +42%; any Middle East or Europe revenue evidence against the softened rhetoric.
- SBC and share count: $265M run-rate trajectory against the Q3 hiring ramp; buyback (absent again); FCF vs CFO convergence toward the raised $4.5–4.7B FY guide.
- SpaceX marks: whether unrealized gains keep flattering GAAP/adjusted EPS comparisons.
- Army Vantage, TITAN, FedStart: any mention after three, five, and six absent quarters.
|
| May 4, 2026 | -6.93% | Q1 FY2026 | Read transcript briefingQuarter in one view- Revenue $1.633B, +85% y/y, +16% q/q — highest growth rate as a public company, eleventh consecutive acceleration (…+63% → +70% → +85%); ~$97M (~6.3%) above the $1.532–1.536B guide high end. "Strongest ever Q1 sequential growth."
- U.S. revenue $1.282B, +104% y/y, +19% q/q — first triple-digit U.S. growth since the DPO; U.S. now 79% of revenue (from 77%). U.S. commercial $595M, +133% y/y (+143% ex a commercial→government program transition), +18% q/q. U.S. government $687M, +84% y/y, +21% q/q — reaccelerated again from +66%.
- Rule of 40 at 145 (from 127, +18pts q/q) — eleventh consecutive expansion. Adjusted op margin 60% (from 57%); AOI $984M. GAAP net income $871M (53% margin). GAAP EPS $0.34 vs adjusted EPS $0.33 — GAAP above adjusted, unexplained on the call.
- Largest-ever FY guide raise: FY2026 revenue to $7.65–7.662B (+71% midpoint, from +61%) — a ~10% raise one quarter after the initial guide. U.S. commercial raised to >$3.224B (≥120%, from ≥115%); AOI to $4.44–4.452B; FCF to $4.2–4.4B; FY Rule of 40 guided to 129 (from 118). Q2 2026: revenue $1.797–1.801B (+10% q/q implied), AOI $1.063–1.067B (~59% margin).
- Headline items: NDR 150% (+1,100bps q/q — a step-function jump); USDA award up to $300M; Maven usage doubled in four months (4x over twelve); ShipOS outcome metrics escalated (200 hrs → 15 sec BOM approval); new agent engine SDK ("agent operating system") announced; Apollo next-gen shipping with a zero-day discovery claim.
What management is focused on- "No-slop zone" as the master narrative: Taylor, Sankar, and Karp all frame AIP as the only platform that converts commodity cognition into governed, auditable, production-grade agent action. The anti-"AI slop" positioning is now the central competitive claim — Palantir as the harness, ontology as "the body to the AI brains."
- Jevons' paradox formalized as the demand thesis: Sankar — GPT-4-equivalent inference is ~1,000x cheaper than early 2023; cheaper tokens → exponentially more agent tasks → more slop → more need for AIP governance. "Tokens are the new coal; AIP is the train." Extended to security: more AI code → more attack surface → more Apollo.
- Death of legacy software: Sankar claims AIP replaces static workflows outright — Thomas Cavanagh Construction at 97% daily Foundry usage with other software failing to "justify its existence"; Palantir replaced its own CRM with an AIP-built tool in months. This is a new, more aggressive TAM claim: AIP as system-of-record replacement, not overlay.
- Warfighter-first resource allocation, stated as policy: Karp says Palantir "100% prioritizes this nation's security over any other variable," tells commercial clients this directly, and surged commercial resources to the defense industrial base. Framed as both values and leverage ("if you want slop, you can go elsewhere").
- Demand-constrained, not demand-seeking: Karp — "our biggest problem… is that we just cannot meet demand"; 70 salespeople, "only seven actually really sell," vs "7,000" at a normal company. FCF this quarter exceeds total revenue of the year-ago quarter.
- Europe deprioritization reiterated and sharpened: Karp has "no time or energy for the waste-of-time machine" in continental Europe — consistent with last quarter's explicit write-down, now with even less ambiguity.
- Cyber/offense as the next platform leg: Sankar claims Mythos/SPUD-class models with AIP found "thousands of zero days" across major OSes and browsers — a "Sputnik moment" — positioning Apollo's remediation chain as the monetizable bottleneck.
Key numbers and quarter mechanics- Segments: commercial $774M (+95% y/y, +14% q/q); government $858M (+76% y/y, +18% q/q). U.S. commercial $595M (+133%; +143% ex-transition — a U.S. commercial customer program moved to U.S. government, which also flattered government growth); international commercial $179M (+26% y/y, +5% q/q — reaccelerated from +8%, though off a small base); U.S. government $687M (+84%); international government $172M (+51% y/y, +7% q/q — reaccelerated from +43%).
- Customers: 1,007 total, +31% y/y, +6% q/q (from 954) — growth decelerating again (+34% → +31%) while revenue accelerates; density-over-volume pattern intact. U.S. commercial customers 615, +42% y/y, +8% q/q (from 571). Top-20 customers $108M TTM each, +55% y/y (from +45% — seventh consecutive acceleration).
- Bookings: total TCV $2.4B, +61% y/y (+135% dollar-weighted duration) — down from $4.3B last quarter, which was renewal-inflated. Commercial TCV $1.3B, +42% y/y. U.S. commercial TCV $1.2B, +45% y/y — third consecutive >$1B quarter, but the y/y growth rate decelerated again (+342% → +67% → +45%); TTM U.S. commercial TCV $4.7B, +115%. Deal-count tiers (≥$10M etc.) not disclosed this quarter.
- Forward metrics: RDV $11.8B, +98% y/y, +6% q/q (from $11.2B; y/y decelerated from +105%). RPO $4.5B, +134% y/y, +9% q/q (from $4.2B; decelerated from +144%). U.S. commercial RDV +112% y/y, +12% q/q (from +145% — third straight deceleration). NDR 150%, +1,100bps q/q — driven by expansions plus the Q1-2025 cohort seasoning; management notes NDR still excludes the newest U.S. cohorts.
- Margins: adjusted gross margin 88% (from 86%); adjusted op margin 60% (from 57%); adjusted OpEx $649M, +7% q/q, +32% y/y (AIP investment, technical hiring) — expense growth roughly stable (+34% → +32% y/y) with margins still expanding. GAAP net margin 53%.
- GAAP quirks: GAAP EPS $0.34 > adjusted EPS $0.33 — unusual inversion, not explained; SBC dollar figure was inaudible in the transcript (equity taxes $28M) — SBC disclosure effectively missing this quarter.
- Cash: CFO $899M (55% margin), adjusted FCF $925M (57%) — FCF > CFO quirk persists, unexplained. Cash/T-bills $8.0B (from $7.2B). No buyback mention.
- Strategic contracts: $3M (0.2% of revenue); guided to <$0.5M per remaining quarter — SPAC drag now fully extinguished.
- Guidance math: Q2 guide implies +10% q/q vs Q1's +16% — sequential deceleration guided again. FY +71% midpoint against Q1's +85% implies deceleration through the year — a more cushioned construction than last quarter's no-deceleration FY guide, and the raise came one quarter in.
Product and launch scorecard- AIP (~3.5 years): strongest external validation yet — AIG's CEO cited on their own earnings call deploying multi-agent underwriting/claims (submissions, risk evaluation, pricing benchmark, fraud detection) coordinated through the ontology; GE Aerospace expanded after a 26% engine-performance gain into production and military aviation supply chain; Motor/Freedom Mortgage end-to-end mortgage rebuild; Ondas/World View scaling stratospheric launches. Still missing: pricing model, paid-conversion, AIP revenue attribution — now thirteen quarters.
- Agent engine SDK (new): announced platform-native agent operating system — unified primitives for building/governing ontology-native agents, per-agent/session/workflow cost attribution with admin caps, full provenance on ontology mutations, security-marking propagation with reclassification approval gates. Framed as what gets "a CISO, a CFO, and a combat commander to say yes." No availability date, pricing, or adoption metrics.
- Maven: usage doubled in four months through March, 4x over twelve months, across services, COCOMs, Joint Staff, and IC — "met its moment across real-world events in Q1" (unspecified). Still no revenue run-rate or ceiling.
- ShipOS: outcome metrics escalated sharply — BOM approval 200 hours → 15 seconds; contract review cycles +57–73% faster; monthly material planning −94%. No revenue recognition detail against the $448M ceiling; no new weapon-system awards disclosed despite last quarter's expansion map.
- Warp Speed: demand "so acute" that commercial resources were surged to the defense industrial base; a private-sector manufacturing program was transitioned and scaled by the government (unnamed — this is also the mechanical explanation for the U.S. commercial ex-transition adjustment). Still no standalone revenue.
- Apollo (re-elevated): next generation now shipping; positioned as the autonomous remediation layer for AI-era vulnerability volume ("thousands of zero days" found by frontier models with AIP). First substantive Apollo airtime in many quarters; no metrics.
- USDA (new vertical): up to $300M ceiling — farmer support, farmland security, supply-chain resilience, fraud/foreign-adversary screening. First large civilian-agency award in recent quarters; ceiling structure, no minimums disclosed.
- Internal dogfooding: Palantir replaced its own CRM with an AIP-built system "in a few months" — used as proof of the legacy-software-death thesis.
- Silent again: Army Vantage (second straight quarter), TITAN (fourth), FedStart (fifth), NHS/U.K. metrics, OSDK API-call metric (not updated), AI Hivemind (not mentioned), Gotham capability suite (not mentioned).
Sell-side read-through- Same structure, eighth consecutive quarter: Wedbush (Ives) and BofA (Perez Mora) live, plus one pre-submitted shareholder question. The call remains effectively unchallenged; the transcript shows the BofA question partially garbled/duplicated, suggesting production issues, but the substance (AI labs in enterprise, talent, Maven budget risk) is discernible.
- Ives's government-vs-commercial balance question produced the quarter's most strategically important answer: Karp's explicit hierarchy — warfighter first, always, with commercial clients told so directly — plus the admission that Palantir is demand-constrained and using scarcity as pricing/scope leverage. Taylor's add: "load-bearing context" customers are driving the U.S.
- Perez Mora's budget question — how much Maven/defense growth depends on FY appropriation vs. surviving a continuing resolution — was not answered quantitatively. Sankar: "history would suggest… we are going to be in a continuing resolution," and the value is "existential… we will realize that value." The single most important risk question on the call got a philosophical answer.
- The pre-submitted AI-pressure question let Sankar restate the counter-positioning thesis (alpha not beta; ontology as the no-slop zone) and Karp issue a verifiable challenge: "dig into the examples of AI actually transforming an enterprise. Call the client… almost every single one is Palantir."
- Unchallenged again: AIP monetization (thirteen quarters), FCF > CFO, SBC run-rate (figure inaudible this quarter), GAAP EPS > adjusted EPS, U.S. commercial TCV deceleration (+45% y/y), U.S. commercial RDV deceleration (+112%), ShipOS revenue vs $448M ceiling, USDA minimums/phasing, Maven revenue, the commercial→government transition's size and one-time vs recurring nature, and the Q2 sequential deceleration to +10% q/q.
Management credibility- Beat-and-raise streak extends to thirteen quarters: ~6.3% above the Q1 high end, and the FY guide raised ~10% one quarter after issuance — the largest raise in company history. The prior quarter's most aggressive claim (FY2026 +61% with no deceleration embedded) was not merely defended but raised to +71%.
- Delivered on the prior watchlist's key items: Q1 vs guide ✓ (beat with 60% adjusted op margin through the hiring ramp); U.S. commercial ex-items ✓ (+143% ex-transition vs 142% prior — held triple digits); U.S. government ✓ (+84%, reaccelerated); NDR ✓ (150%, a step-function up); international commercial ✓ partially (+26% vs +8% — reaccelerated despite stated deprioritization); Maven ✓ (usage doubling quantified); ShipOS ✓ (outcome metrics escalated); new funded vehicle ✓ (USDA $300M).
- Guidance posture improved in quality: last quarter's FY guide embedded zero deceleration; this quarter's +71% against an +85% Q1 embeds meaningful deceleration — a more credible construction, and Q2's +10% q/q guide is conservative against Q1's +16%.
- Debits: U.S. commercial leading indicators decelerated again (TCV +45% y/y, RDV +112% y/y — both down for the third straight reading) and went unaddressed; SBC figure inaudible with no run-rate disclosure; GAAP EPS exceeding adjusted EPS unexplained; the CR-dependency question was evaded; the commercial→government program transition was disclosed only as a growth-rate adjustment with no dollar size; deal-count disclosures dropped this quarter.
- Consistency check: NDR 150%, top-20 +55%, TTM U.S. commercial TCV +115%, and the named-customer evidence (AIG, GE Aerospace, Motor/Freedom Mortgage) corroborate the acceleration. The tension remains between accelerating revenue and decelerating bookings-growth rates in the flagship segment — management's density-over-volume framing covers it, but the gap is widening.
What changed versus the prior quarter- Growth: total +70% → +85%; U.S. +93% → +104%; U.S. commercial +137% → +133% headline but +142% → +143% ex-items (held); U.S. government +66% → +84%; international commercial +8% → +26% (reaccelerated despite deprioritization); international government +43% → +51%.
- Bookings: TCV $4.3B → $2.4B (+138% → +61% y/y — normalizing off the renewal-inflated Q4); U.S. commercial TCV $1.3B → $1.2B (+67% → +45% y/y — decelerated again); RDV +105% → +98% y/y; RPO +144% → +134% y/y; NDR 139% → 150% (+1,100bps — the quarter's standout forward metric).
- Margins: adjusted op margin 57% → 60%; adjusted gross 86% → 88%; GAAP net margin 43% → 53%; Rule of 40 127 → 145. OpEx +34% → +32% y/y.
- Guidance: FY2026 revenue +61% → +71% midpoint; U.S. commercial ≥115% → ≥120%; AOI $4.126–4.142B → $4.44–4.452B; FCF $3.925–4.125B → $4.2–4.4B; FY Rule of 40 118 → 129. Q2 implies +10% q/q vs Q1's +16%.
- Narrative: "N of 1" retained, but the center of gravity shifted to anti-slop governance (agent SDK, provenance, cost attribution), Jevons' paradox as formal demand theory, legacy-software replacement (CRM dogfooding, Cavanagh 97%), and Apollo/cyber as a new leg. Europe rhetoric hardened further.
- Watchlist resolution vs prior packet: Q1 vs guide ✓; FY guide held and raised ✓; U.S. commercial ex-items ✓ (143%); ShipOS revenue recognition ✗ (metrics yes, dollars no); Maven ✓ (usage quantified; revenue ✗); Army Vantage ✗ (second silent quarter); U.S. government ✓ (+84%); international ✓ (commercial reaccelerated to +26%; no Middle East revenue evidence given); RPO normalization ✓ (growth moderated to +134%, +9% q/q); OSDK metric ✗ (not updated); SBC run-rate ✗ (inaudible); AIP monetization ✗ (thirteenth quarter); FCF vs CFO ✗; TITAN ✗ (fourth); FedStart ✗ (fifth); buyback ✗.
Bull case- Acceleration is eleven quarters deep and still steepening: +85% on a $1.6B quarter, U.S. at +104%, with the FY guide raised ~10% to +71% one quarter in — and the new guide embeds deceleration from the Q1 run rate, making it the most credible aggressive guide the company has issued.
- NDR at 150% (+1,100bps) with management noting it still excludes the newest U.S. cohorts — the expansion engine is accelerating even as the base triples, and top-20 revenue per customer (+55% to $108M) accelerated for the seventh straight quarter.
- Third-party validation is now coming from customers' own platforms: AIG's CEO describing ontology-coordinated agentic underwriting on AIG's own earnings call; GE Aerospace expanding on a quantified 26% engine-performance gain. Karp's "call the client" challenge is checkable — and the named evidence supports it.
- The government book broadened beyond defense: USDA up to $300M opens a civilian-agency vertical; Maven usage doubling in four months across services, COCOMs, Joint Staff, and IC; ShipOS metrics (200 hrs → 15 sec) suggest deep production embedment; a commercial manufacturing program was adopted and scaled by the government — a new land-and-expand motion across segments.
- Operating leverage at an extreme: 60% adjusted op margin, 53% GAAP net margin, Rule of 40 145, FCF $925M exceeding the entire year-ago quarter's revenue — with OpEx still growing 32% and a demand-constrained (not sales-constrained) posture with effectively seven quota-carrying sellers.
- The agent SDK and Apollo reposition Palantir for the next enterprise bottleneck — governance, cost attribution, and remediation of agentic AI — with the zero-day claim suggesting an offensive-security TAM that was not in any prior narrative.
Bear case- The flagship segment's leading indicators decelerated for the third straight reading: U.S. commercial TCV +342% → +67% → +45% y/y; U.S. commercial RDV +199% → +145% → +112% y/y; total RDV +105% → +98%; RPO +144% → +134%. Revenue is accelerating on yesterday's bookings; today's bookings growth is slowing — unaddressed on the call.
- Sequential deceleration is guided again: Q2 +10% q/q after Q1's +16%, which was itself guided down from +19%. The FY +71% guide requires the deceleration to stop soon; each quarter's beat has been partly financed by raising the bar for the next.
- Headline growth required an adjustment: U.S. commercial's +133% vs +143% ex-transition reveals a program large enough to move segment growth by 10 points being reclassified to government — undisclosed in size, timing, or recurrence, and it flattered U.S. government growth symmetrically.
- Contract structures remain ceilings: USDA $300M, ShipOS $448M, Maven — no minimums, phasing, margins, or revenue recognition disclosed. The CR-dependency question — the most direct risk query of the call — received no quantitative answer.
- Disclosure quality slipped this quarter: SBC figure inaudible with no run-rate; GAAP EPS ($0.34) exceeding adjusted EPS ($0.33) unexplained; deal-count tiers dropped; FCF > CFO unexplained for the thirteenth-plus quarter; AIP monetization absent for the thirteenth.
- Concentration and conduct risk are compounding: 79% U.S. revenue, explicit warfighter-first resource triage over commercial clients, hardened Europe rhetoric, and Karp's continued political commentary — all discretionary exposures. The two-friendly-questioner format (eight quarters) ensures none of the above gets examined on the call.
Next-quarter watchlist- Q2 2026 vs $1.797–1.801B revenue (+10% q/q implied) and $1.063–1.067B AOI (~59% margin): does the sequential deceleration stop at +10%, and does the FY +71% / Rule of 40 129 guide hold or get raised again?
- U.S. commercial: growth vs the +133%/+143% ex-transition print; TCV against $1.2B with the +45% y/y deceleration in focus; RDV from +112% y/y; progress toward >$3.224B / ≥120% FY guide; customer adds from 615; NDR sustainability at 150% as the Q1-2025 cohort fully seasons into the base.
- The commercial→government program transition: dollar size, one-time vs recurring, margin impact, and whether more transitions follow — it moved both segments' growth rates by ~10 points.
- ShipOS: first revenue disclosure against the $448M ceiling; expansion beyond maritime (fighters, bombers, munitions) as signaled two quarters ago; whether the 200-hrs→15-sec metrics convert to follow-on awards.
- USDA: minimums, phasing, first revenue; whether civilian agencies become a repeatable third leg.
- Maven: whether the 4x usage curve produces a revenue run-rate or ceiling disclosure; MAGE/edge follow-ons; COCOM rollout completion.
- Agent engine SDK: availability date, pricing, early adopters; whether cost-attribution/provenance features become a monetizable tier — the first credible answer to the thirteen-quarter AIP monetization question if priced separately.
- Apollo: evidence behind the "thousands of zero days" claim; customer adoption of the next-gen release; any security-specific revenue framing.
- U.S. government: sustainability of +84% ex the transitioned program; CR dynamics and FY2026 appropriation progress — the question management declined to quantify.
- International: whether commercial +26% holds or was base-effect noise; any Middle East revenue evidence; international government durability at +51%.
- SBC: the actual Q1 figure (inaudible on the call) and any forward run-rate; share count; buyback (absent again).
- GAAP vs adjusted EPS inversion: explanation and whether it recurs.
- Cash: FCF vs CFO convergence; trajectory toward the raised $4.2–4.4B FY FCF guide.
- Army Vantage, TITAN, FedStart: any mention after two, four, and five absent quarters; deal-count disclosure restoration.
|
| Feb 2, 2026 | +6.85% | Q4 FY2025 | Read transcript briefingQuarter in one view- Revenue $1.407B, +70% y/y, +19% q/q — highest growth rate as a public company; ~900bps above the high end of the $1.327–1.331B guide; tenth consecutive acceleration quarter (…+48% → +63% → +70%). Ex-strategic-contracts +72% y/y. FY2025 revenue $4.475B, +56%.
- U.S. revenue $1.076B, +93% y/y, +22% q/q — first $1B+ U.S. quarter; now 77% of revenue (from 75%). U.S. commercial $507M, +137% y/y (+142% ex-SPAC), +28% q/q — accelerating off 121%/126%. U.S. government $570M, +66% y/y, +17% q/q — reaccelerated from +52%.
- Rule of 40 at 127 (from 114, +13pts q/q, +46pts y/y) — tenth consecutive expansion; FY2025 Rule of 40 106 vs 102 guided. Adjusted operating margin 57% (from 51%), ~500bps above guide. GAAP operating income $575M (41% margin, from 33%); GAAP net income $609M (43%).
- Massive FY2026 guide: revenue $7.182–7.198B (+61% midpoint) vs a ~31% initial FY2025 guide a year ago; U.S. commercial >$3.144B (≥115% growth); AOI $4.126–4.142B (~57% implied margin); adjusted FCF $3.925–4.125B; FY2026 Rule of 40 guided to 118. Q1 2026: revenue $1.532–1.536B (+~61% y/y implied, +9% q/q), AOI $870–874M (~57% margin).
- Headline items: record TCV $4.3B (+138% y/y, +54% q/q) — eclipsing last quarter's record by >$1.5B; RPO $4.2B (+144% y/y, +62% q/q) — the prior quarter's one lagging metric inflected sharply; Navy award up to $448M for shipbuilding supply chain (ShipOS); NDR 139% (from 134%).
What management is focused on- "N of 1" framing replaces "best results ever": Karp and Taylor argue Palantir is a category of one — Rule of 127, 70% growth, 93% U.S. growth as proof the company is untethered from any software category. Karp: "one of the truly iconic performances in the history of corporate performance."
- Value-stack inversion thesis: value sits at the top of the stack (ontology, FDE, orchestration, "tribal knowledge"), not in commoditized LLMs; Karp explicitly contrasts Palantir's margins with model-layer economics ("making revenue with no way of making profit… not valuable"). "Commoditization of cognition" is Taylor's framing — Palantir sells the leverage, not the cognition.
- Fully organic purity: Karp stresses no acquisitions and "no intertwined economics" — no co-investing, no circular revenue, direct client relationships. This reads as a deliberate contrast with AI-ecosystem circularity concerns elsewhere in the market.
- International deprioritization is now explicit strategy, not a soft spot: Karp says Palantir lacks bandwidth for "difficult" non-U.S. work, blames European procurement structures ("is the purchasing structure… allowed to bear the load of buying the best product?"), and cites adoption in the Middle East (Arab states and Israel) and China vs non-adoption in Canada/Northern Europe. No reacceleration commitment was made.
- Density over volume: Karp states the 2026 goal is "much more density of client base than volume" — deeper transformation of large institutions, with CEOs personally in the weeds of deployments; Palantir is increasingly "shaping who we work with."
- ShipOS / reindustrialization as the next platform narrative: Navy shipbuilding supply chain award, planning time 160 hours → 10 minutes at one shipbuilder, material review weeks → <1 hour at a shipyard, a customer adding a third shift (framed as Jevons paradox — AI creating jobs). Sankar says demand is extending to fighters, bombers, surface vessels, drones, munitions — "factory floor to foxhole."
- Maven at all-time-high usage, expanding to all combatant commands and more networks this government fiscal year; new Maven Edge agent "MAGE" completed a live-fire exercise coordinating UAV assets with onboard planning.
- Karp's political/civilizational commentary continues (European political drift, "lethal on the front end," Fourth Amendment framing for domestic work) — slightly less campaign-style than last quarter but still unprompted and extended.
Key numbers and quarter mechanics- Segments: commercial $677M (+82% y/y, +23% q/q; +86% ex-SPAC); government $730M (+60% y/y, +15% q/q). U.S. commercial $507M (+137%/+142% ex-SPAC); international commercial $171M (+8% y/y, +12% q/q; FY +2% — still near-flat); U.S. government $570M (+66%); international government $160M (+43% y/y, +9% q/q — decelerated from +66%, again "bolstered primarily by continued work in the U.K.").
- Customer count 954, +34% y/y, +5% q/q (from 911) — note customer growth continues to decelerate (+45% → +34% y/y) while revenue accelerates; Karp leans into this ("inexplicable growth in revenue, but not inexplicable growth in customers"). U.S. commercial customers 571, +49% y/y, +8% q/q (from 530). Top-20 customers $94M TTM each, +45% y/y (from +38% — sixth consecutive acceleration).
- Bookings: TCV $4.3B, +138% y/y, +54% q/q; +166% on a dollar-weighted duration basis. Commercial TCV $2.6B (+161% y/y, +83% q/q). U.S. commercial TCV $1.3B (+67% y/y — decelerated sharply from +342%, though flat sequentially at a high base); FY2025 U.S. commercial TCV $4.3B, +161%. International commercial TCV $1.3B — driven by "long-term renewals with several long-standing international commercial customers," i.e., renewal-heavy, not new-demand-driven. 61 deals ≥$10M (vs 53 last quarter; other deal-count tiers not disclosed this quarter).
- Forward metrics: total remaining deal value $11.2B, +105% y/y, +29% q/q (from $8.6B). RPO $4.2B, +144% y/y, +62% q/q (from $2.6B) — the divergence flagged last quarter resolved violently upward, aided by the international long-term renewals; standard government-exclusion caveat repeated. NDR 139%, +500bps q/q. U.S. commercial remaining deal value +145% y/y, +21% q/q (decelerated from +199%).
- Margins: adjusted gross margin 86% (from 84%); adjusted op margin 57% (from 51%); adjusted OpEx $608M, +5% q/q, +34% y/y (AIP and technical hiring) — expense growth accelerating (+29% → +34% y/y) yet margins still expanded 600bps. FY2025 AOI $2.254B (50% margin, +1,100bps y/y).
- GAAP: Q4 operating income $575M (41%); net income $609M (43%); GAAP EPS $0.24; adjusted EPS $0.25. FY GAAP EPS $0.63, adjusted $0.75. SBC $196M in Q4 (from $172M), equity taxes $27M; FY SBC $684M + $156M taxes — SBC still climbing, forward run-rate still undisclosed.
- Cash: Q4 CFO $777M (55%), adjusted FCF $791M (56%) — FCF > CFO quirk persists. FY CFO $2.13B (48%), FCF $2.27B (51%), +82% y/y. Cash/T-bills $7.2B (from $6.4B). No buyback update given this quarter.
- Strategic commercial contracts: $2.1M in Q4 (0.1% of revenue); Q1 2026 guided $1–3M vs $5.1M in Q1 2025; FY2026 <$7M (<0.1%) — SPAC drag fully immaterial.
- Guidance math: Q1 2026 guide of $1.532–1.536B implies ~+61% y/y and +9% q/q — a sequential deceleration from +19% q/q, though against the toughest comp yet. FY2026 +61% midpoint with Q1 at ~+61% implies management expects growth to hold roughly flat across the year — an extraordinarily demanding guide with no deceleration embedded.
- Transcript quirks: Sankar references "Department of War" (consistent with current administration usage); Karp cites the initial FY2025 guide as "roughly in the 30%"/"31%" (actual initial guide was ~31%); unclear bracketed terms ([Kyvos], [sync matrices]) in the Gotham capability description.
Product and launch scorecard- AIP (~3 years): strongest evidence yet — U.S. commercial +137%/+142% ex-SPAC, NDR 139%, 61 deals ≥$10M, utility expanding $7M → $31M ACV within 2025, energy company $4M → $20M+ ACV, healthcare company signing $96M after two boot camps, engineering services firm signing $80M after fall demos. Lear: 100 users/4 use cases → 16,000 users/280 use cases. Still missing: pricing model, paid-conversion rate, AIP revenue attribution — now twelve quarters.
- AI FDE: capability expansion disclosed — now powering SAP ECC → S/4HANA migrations "in as little as 2 weeks" (vs the 5-day data-warehouse migration last quarter); generalizing to broader problem sets. No new productivity metric this quarter (last quarter's headcount +10% vs revenue +63% not updated).
- OSDK: first scale metric — >1 billion API gateway requests per week from customer-built applications on AIP. Best evidence yet of the builder-platform motion.
- AI Hivemind: new use case — generating bespoke customer-specific AIP demos from public information only; "closing the loop" between Hivemind output and autonomous execution is the stated investment priority. Still no metrics or monetization.
- Maven: usage at all-time highs; rollout to all combatant commands and more networks this government fiscal year; MAGE (Maven Edge agent) completed a live-fire UAV-coordination exercise — first concrete edge/autonomy milestone. Still no revenue run-rate or ceiling update.
- ShipOS (new, on Warp Speed): the quarter's flagship launch — Navy award up to $448M; quantified outcomes (160 hrs → 10 min planning; weeks → <1 hr material review; third shift added); dedicated American Tech Fellowship for the submarine industrial base launching this month. Sankar signals extension to fighters, bombers, surface vessels, drones, munitions. First Warp Speed family product with a dollar figure attached.
- Warp Speed: additional proof points — root-cause analysis coverage <20% → >99% in under a week (mature weapon system); 40x throughput improvement (new weapon system). Still no standalone revenue or pricing.
- Gotham: new integrated capability suite named — platform-run Foundry, integrated planning, Nexus (dynamic command relationships/unit task hierarchies), Workbench (collections, fires, battle damage assessment automation). No metrics.
- Army Vantage: not mentioned this quarter — no update on conversion of last quarter's consolidation memo into funded orders.
- TITAN: not mentioned for the third consecutive quarter. FedStart: not mentioned for the fourth consecutive quarter. NHS/U.K.: no metrics for the fourth straight quarter despite U.K. driving international government.
Sell-side read-through- Same two sell-side questioners for the seventh consecutive quarter: BofA (Perez Mora) and Wedbush (Ives); one pre-submitted shareholder question on international. The call remains effectively unchallenged.
- Perez Mora's commercial question (has customer resistance to AI adoption changed?) drew the most useful demand-side color: Karp described inbound customers arriving pre-sold on proof points ("I've heard you made this work… what do I need to do to make this accelerate?"), Palantir actively shaping its client base, and CEOs personally running deployments. Her ShipOS question drew the "factory floor to foxhole" expansion map (fighters, bombers, munitions, plus pharma and data centers via "chain reaction").
- Ives asked a soft budget-share question; Karp's answer contained one analytically important framing: revenue growth is deliberately decoupling from customer growth because serious customers are concentrating their most important problems (and budgets) with Palantir — "density of client base than volume."
- The international shareholder question produced the quarter's most consequential strategic disclosure: Karp effectively deprioritized Europe/Canada, citing bandwidth constraints and allied procurement dysfunction, and made no commitment to reacceleration — a direct answer that international commercial (+8% y/y, FY +2%) is a choice, not just a market condition.
- Unchallenged again: AIP monetization/pricing (twelve quarters), FCF > CFO, Army EA/Vantage memo economics (now compounded by Vantage going unmentioned), Maven revenue run-rate, Warp Speed/ShipOS revenue split within the $448M ceiling, SBC forward run-rate, U.S. commercial TCV deceleration (+342% → +67% y/y), international commercial TCV being renewal-driven, and how much of the FY2026 +61% guide is covered by the $11.2B remaining deal value. Nobody asked about the Q1 sequential deceleration to +9% q/q.
Management credibility- Beat-and-raise streak extends to twelve quarters: ~900bps above the Q4 high end; FY2025 finished at +56% vs an initial ~31% guide — a 25-point intra-year raise across the year. FY2025 Rule of 40 guided at 102, delivered 106.
- Delivered on the prior watchlist's key items: Q4 expense increase did not dent margins (adjusted op margin 51% → 57%; GAAP 33% → 41%); U.S. commercial ex-SPAC accelerated again (126% → 142%) off extreme comps; U.S. government reaccelerated (+52% → +66%); NDR (139%) and top-20 (+45%) accelerated again; RPO inflected (+66% → +144% y/y) — the one soft forward metric resolved; Maven got a substantive update (all-time-high usage, COCOM rollout, MAGE live-fire) after a silent quarter.
- Guidance posture: FY2026 +61% with Q1 at ~+61% embeds zero deceleration across the year — the most aggressive annual guide the company has ever issued, and the first where the full-year growth rate matches the entering quarterly rate. Credibility from twelve beats supports it, but there is no cushion in the construction.
- Debits: U.S. commercial TCV decelerated hard (+342% → +67% y/y) and U.S. commercial remaining deal value decelerated (+199% → +145%) — both unaddressed; international commercial TCV was renewal-driven, not new demand; Army Vantage memo conversion went unmentioned one quarter after being the headline strategic item; SBC up to $196M with no forward run-rate; FCF > CFO unexplained for the twelfth-plus quarter; no buyback disclosure.
- Consistency check: NDR (139%), top-20 (+45%), remaining deal value (+105%), RPO (+144%), TCV (+138%), and the ACV expansion examples all corroborate the acceleration narrative. The soft spots are now U.S. commercial bookings growth rates (still enormous in dollars) and customer-count deceleration — both consistent with the stated density-over-volume strategy, but worth monitoring as leading indicators.
What changed versus the prior quarter- Growth: total +63% → +70% (ex-SPAC +65% → +72%); U.S. commercial +121% → +137% headline, ex-SPAC +126% → +142%; U.S. government +52% → +66% (reaccelerated); international commercial +10% → +8% y/y (stalled; FY +2%); international government +66% → +43% y/y (decelerated, still U.K.-driven).
- Bookings: TCV $2.8B → $4.3B (+151% → +138% y/y); U.S. commercial TCV $1.3B → $1.3B (+342% → +67% y/y — sharp deceleration); remaining deal value +91% → +105%; RPO +66% → +144% y/y (inflected — resolves last quarter's divergence); NDR 134% → 139%.
- Margins: AOI margin 51% → 57%; GAAP op margin 33% → 41%; GAAP net margin 40% → 43%; Rule of 40 114 → 127. OpEx +29% → +34% y/y — investment accelerating, margins expanding anyway.
- Guidance: new FY2026 guide — revenue +61% midpoint, U.S. commercial ≥115%, AOI ~57% margin, FCF $3.925–4.125B, Rule of 40 118. Q1 2026 implies +9% q/q vs Q4's +19% q/q — sequential deceleration guided.
- Watchlist resolution vs prior packet: Q4 vs guide ✓ (beat by ~900bps, margins up through the expense ramp); U.S. commercial ex-SPAC ✓ (142%, accelerated again); Army Vantage memo conversion ✗ (no update — Vantage unmentioned); Maven ✓ (usage highs, COCOM rollout, MAGE); U.S. government ✓ (+66%); international commercial ✗ (stalled at +8%, FY +2%, and management explicitly deprioritized Europe); RPO vs RDV divergence ✓ (resolved upward); AI FDE/Hivemind/Edge ✓ partially (SAP migrations, OSDK 1B API calls, MAGE — still no monetization); SBC run-rate ✗; AIP monetization ✗ (twelfth quarter); FCF vs CFO ✗; Warp Speed revenue ✗ partially (ShipOS has a $448M ceiling — first dollar figure in the family); TITAN ✗ (absent third quarter).
Bull case- Acceleration is ten quarters deep and still steepening at scale: +70% on a $1.4B quarter, ex-SPAC +72%, with FY2026 guided to +61% — a guide that embeds no deceleration and follows twelve consecutive beats, including a 25-point intra-year raise in 2025.
- U.S. commercial keeps compounding off its own acceleration: +137% y/y (+142% ex-SPAC), +28% q/q, with large-deal evidence ($96M healthcare, $80M engineering services) and extreme expansion velocity ($7M → $31M ACV in-year; Lear 100 → 16,000 users). FY2026 guided to ≥115% growth — management is guiding another year of triple-digit growth on a $1.5B base.
- Forward cover is unprecedented: remaining deal value $11.2B (+105%), RPO $4.2B (+144%, +62% q/q), NDR 139%, TCV $4.3B — bookings and obligations running far ahead of revenue, and the RPO inflection removes the one lagging indicator.
- Operating leverage keeps compounding: adjusted op margin 57%, GAAP op margin 41%, Rule of 40 127, FY2026 Rule of 40 guided to 118 — with OpEx growing 34% y/y, the "invest and expand" claim has now held for three straight quarters of hiring ramps.
- ShipOS gives the reindustrialization thesis its first funded vehicle: $448M Navy ceiling, quantified outcomes, and a stated expansion path across weapon systems — plus Maven at all-time-high usage rolling out to all combatant commands.
- The density-over-volume strategy is working by the numbers: customer growth decelerating (+34%) while revenue accelerates (+70%) is exactly what management says it is doing — and NDR 139% plus top-20 +45% corroborate it.
Bear case- The FY2026 guide embeds perfection: +61% for the year with Q1 at +61% means no deceleration is priced into guidance against the hardest comps of the cycle; Q1's +9% q/q sequential guide is already a step down from +19% — any further sequential slowdown breaks the full-year math.
- U.S. commercial bookings momentum decelerated sharply beneath the revenue headline: TCV +342% → +67% y/y, remaining deal value +199% → +145% y/y. Dollars are still enormous, but the leading edge of the most important segment is decelerating — unaddressed on the call.
- International is now a stated strategic write-down, not a fixable drag: commercial +8% y/y (FY +2%), the $1.3B international TCV was renewal-driven, and Karp explicitly cited bandwidth constraints and allied procurement dysfunction with no reacceleration commitment. The business is 77% U.S. and concentrating.
- Headline contract structures remain ceilings, not revenue: $448M Navy/ShipOS, $10B Army EA, Vantage memo (unmentioned this quarter), Maven rollout — none have disclosed minimums, phasing, or margins.
- Disclosure gaps are twelve quarters deep on the central questions: AIP pricing/monetization, Maven revenue run-rate, Warp Speed/ShipOS revenue split, SBC forward run-rate ($196M and climbing), FCF > CFO.
- Self-inflicted risk persists: Karp's extended political and civilizational commentary (European politics, "lethal on the front end") remains a deliberate, discretionary exposure; the call format (two friendly questioners, seven quarters running) means none of the soft spots above were examined.
Next-quarter watchlist- Q1 2026 vs $1.532–1.536B revenue (+~61% y/y, +9% q/q) and $870–874M AOI (~57% margin): does the sequential deceleration stop at +9%, and does the FY2026 +61% / Rule of 40 118 guide hold?
- U.S. commercial: ex-SPAC growth off the 142% print; TCV against $1.3B with the +67% y/y deceleration in focus; progress toward >$3.144B / ≥115% FY guide; customer adds from 571; whether density-over-volume keeps NDR at 139%.
- ShipOS: first revenue recognition against the $448M ceiling; expansion to additional weapon systems (fighters, bombers, munitions) as Sankar signaled; submarine industrial base Tech Fellowship outcomes.
- Maven: COCOM rollout progress, MAGE follow-ons, any revenue run-rate or ceiling update.
- Army Vantage: any funded orders or revenue attributable to the consolidation memo after a silent quarter; EA minimums/phasing/margins.
- U.S. government: sustainability of +66%; international government after decelerating to +43% (U.K. concentration).
- International: does commercial +8% deteriorate further given explicit deprioritization; any Middle East (Arab states/Israel) revenue evidence behind Karp's adoption claims.
- U.S. commercial remaining deal value from +145% y/y; total RDV from $11.2B; RPO from $4.2B — does the renewal-driven RPO spike repeat or normalize?
- AI FDE / Hivemind / OSDK: adoption counts, availability terms, monetization; whether the 1B weekly API calls metric is updated.
- SBC: forward run-rate disclosure; share count and any buyback update (none given this quarter).
- AIP monetization, twelve quarters overdue: pricing, paid-conversion, or revenue attribution.
- Cash: FCF vs CFO convergence; trajectory toward the $3.925–4.125B FY2026 FCF guide.
- TITAN and FedStart: any mention after three and four absent quarters, respectively.
|
| Nov 3, 2025 | -7.94% | Q3 FY2025 | Read transcript briefingQuarter in one view- Revenue $1.181B, +63% y/y, +18% q/q — ~1,300bps above the high end of the $1.083–1.087B guide; ninth consecutive acceleration quarter (+17% → +20% → +21% → +27% → +30% → +36% → +39% → +48% → +63%). Glazer frames it as a 3,300bps improvement vs Q3 last year's growth rate. Ex-strategic-contracts +65% y/y.
- U.S. revenue $883M, +77% y/y, +20% q/q — now 75% of the business (from 73%). U.S. commercial $397M, +121% y/y (+126% ex-SPAC), +29% q/q — 34% of Q3 revenue vs 31% last quarter. U.S. government $486M, +52% y/y, +14% q/q — essentially holding last quarter's +53% breakout.
- Rule of 40 at 114 (from 94, +20pts q/q) — ninth consecutive quarter of expansion; FY Rule of 40 guided to 102 (from 91). Adjusted operating margin 51% (from 46%), ~500bps above the high end of guide. GAAP operating income $393M (33% margin, from 27%). GAAP net income $476M (40%). Adjusted FCF $540M (46% margin); trailing-12-month adjusted FCF hit $2B for the first time.
- Another large guidance raise: FY2025 revenue to $4.396–4.400B (+53% midpoint, from +45% — an 8-point / $252M raise); U.S. commercial to >$1.433B (≥104% growth, from ≥85% — a 19-point raise in 90 days); AOI to $2.151–2.155B; adjusted FCF to $1.9–2.1B. Q4: revenue $1.327–1.331B (+61% y/y, +13% q/q — highest-ever sequential guide again), AOI $695–699M (~52% implied margin).
- Headline strategic items: U.S. Army issued an official public memo directing all Army organizations to consolidate and centralize on Vantage (built on Foundry/AIP) — framed as a cultural, not just technical, decision enabling legacy-system sunsets; record TCV $2.8B (+151% y/y), eclipsing last quarter's record by ~$0.5B; U.S. commercial TCV $1.3B (+342% y/y), first $1B+ U.S. commercial bookings quarter.
What management is focused on- "Best results any software company has ever delivered": Karp opens with that claim, anchors it on Rule of 40 of 114, >100% U.S. commercial growth, and 77% U.S. growth "off of a massive significant base" — and explicitly blames "stagnant Europe" for holding the consolidated number down. Rhetoric has escalated from "anomalous quarter" to a civilizational framing.
- Value-capture thesis sharpened: Palantir is "downstream from the value creation" — customers pay "a subset" of the money Palantir makes them. Karp frames the model as "private equity-like transformation in the public markets" — enterprise-wide reorgs around AIP, done in months, under current leadership, without going private.
- AI FDE moves from concept to production evidence: Sankar cites 2 human FDEs spawning "an army of AI FDEs" to migrate a customer off a legacy data warehouse in 5 days vs "an army of SIs up to 2 years" — "not a prototype… production across our customers." Internally, headcount grew ~10% while revenue grew 63% — the first quantified productivity claim for AI FDE. Also tied to Army Vantage: a generation of "green suiters" whose first software interaction will be AI FDE.
- New product: AI Hivemind — dynamically generated agent orchestration for hard problem-solving, idea refinement, and executable proposal generation, ontology-aware. Originated in classified work; already used by commercial customers for supply-chain bottlenecks (Hivemind proposes, AI FDE codes the solution); in government, generates mission plans in Gaia and Maven ("Maverick" per transcript, likely Maven).
- New product: Edge Ontology — lightweight ontology implementation running on mobile devices, for mobile apps and embedded software on drones/robots, integrated with the enterprise AIP instance. Extends AIP "to the far edge."
- C-suite ownership as the demand driver: Taylor's pattern — customers now arrive asking "how do we deploy this across our entire organization," not for a single use case. Proof points: medical device manufacturer expanded 5 months after initial contract, ACV up >8x, CEO pursuing "AI-first enterprise" 2 weeks in; insurance CEO personally orchestrating company-wide AIP transformation (underwriting to claims); TWG Global's Vergence.ai partnership with Thomas Tull quote ("competitive advantage → competitive necessity").
- American-worker narrative continues: American Tech Fellowship second cohort wrapping; named fellows (civil engineer, potato farm worker, utilities expert); customers including Lear now asking Palantir to run fellowship programs for their own employees — Lear highlighted it on its own earnings call.
- Karp's political positioning is now explicit and extended on the call: ICE, Ukraine, Israel, border/fentanyl, "anti-woke," open-border critique — delivered unprompted in Q&A. This is a deliberate identity strategy, but it is also a reputational and political-risk exposure management is choosing to amplify.
Key numbers and quarter mechanics- Segments: commercial $548M (+73% y/y, +22% q/q; +77% ex-SPAC) — fourth consecutive quarter commercial > U.S. government; government $633M (+55% y/y, +14% q/q). U.S. commercial $397M (+121%/+126% ex-SPAC, +29% q/q); international commercial $152M (+10% y/y, +5% q/q — first positive y/y after three straight declines); U.S. government $486M (+52%, +14% q/q); international government $147M (+66% y/y, +16% q/q — reaccelerated from +37%, again "bolstered primarily by continued work in the U.K.").
- Customer count 911, +45% y/y, +7% q/q (from 849). U.S. commercial customers 530, +65% y/y, +9% q/q (from 485). Top-20 customers $83M TTM each, +38% y/y — fifth consecutive acceleration (+12% → +18% → +26% → +30% → +38%).
- Bookings: record TCV $2.8B, +151% y/y. 204 deals ≥$1M, 91 ≥$5M, 53 ≥$10M (from 157/66/42). Commercial TCV $1.4B, +132% y/y, +32% q/q. U.S. commercial TCV $1.3B, +342% y/y — first time above $1B; Taylor cites >6x y/y on a dollar-weighted duration basis; U.S. commercial deal mix: 83 ≥$1M, 40 ≥$5M, 21 ≥$10M. Trailing-12-month U.S. commercial TCV $3.8B, +217%. U.S. commercial remaining deal value +199% y/y, +30% q/q.
- Total remaining deal value $8.6B, +91% y/y, +21% q/q (from $7.1B). RPO $2.6B, +66% y/y, +8% q/q (from $2.4B) — note RPO growth decelerated (+77% → +66% y/y) even as remaining deal value accelerated; Glazer repeats the caveat that RPO excludes most government contract structures. NDR 134%, +600bps q/q (128% → 134%), driven by expansions plus the Q3-2024 cohort seasoning in; standard 12-month exclusion caveat repeated.
- Margins: adjusted gross margin 84% (from 82%); adjusted op margin 51% (from 46%); adjusted OpEx $581M, +8% q/q, +29% y/y (AIP and technical hiring). The guided Q3 hiring ramp happened and margins still expanded 500bps — the "invest and expand" claim delivered again. Q4 expenses guided to increase further.
- GAAP: operating income $393M (33% margin, from 27%); net income $476M (40%); GAAP EPS $0.18; adjusted EPS $0.21. SBC $172M plus $35M employer equity taxes (from $160M/$35M) — SBC creeping up; forward run-rate still not guided.
- Cash: CFO $508M (43%), adjusted FCF $540M (46%) — FCF > CFO quirk persists. TTM adjusted FCF $2.0B. Cash/T-bills $6.4B (from $6.0B). Buyback ~2.6M shares cumulative (from ~2.5M); $880M remaining — still token against $172M quarterly SBC.
- Strategic commercial contracts: $2.9M revenue in Q3 (within the $2–4M guide); Q4 guided to $2–4M vs $9.6M in Q4 2024; FY2025 <0.5% of revenue — SPAC drag fully lapped.
- Guidance math: Q4 guide implies +61% y/y and +13% q/q — acceleration guided again. FY midpoint +53% with 9M actuals implies Q4 roughly at guide; the FY raise of $252M is slightly larger than the Q3 beat vs guide (~$95–98M above high end), implying some Q4 upside embedded beyond the beat.
- Transcript quirks: Sankar says "Maverick" where context indicates Maven; Karp references "141%" growth (no such figure disclosed this quarter — likely a loose reference); Taylor's U.S. commercial deal-count figures (83/40/21) are a subset of the company-wide 204/91/53. No units error in prepared remarks this quarter (the prior two quarters had $1M/$1B slips).
Product and launch scorecard- AIP (~2.75 years): strongest quarter yet — U.S. commercial +121% (+126% ex-SPAC), TCV +342%, NDR 134%, 53 deals ≥$10M, >8x ACV expansion in 5 months at a medical device manufacturer. Still missing: pricing model, paid-conversion rate, AIP revenue attribution — now eleven quarters.
- AI FDE: first production evidence and first productivity metric — 5-day legacy data warehouse migration vs up to 2 years with SIs; headcount +10% vs revenue +63%; positioned as the onboarding layer for Army Vantage users. Still no standalone adoption counts, availability terms, or monetization.
- AI Hivemind (new): classified-origin agent orchestration now in commercial use (supply-chain bottleneck identification → AI FDE implementation) and government mission planning in Gaia/Maven. No metrics; strategically extends the "enterprise autonomy" roadmap.
- Edge Ontology (new): lightweight ontology on mobile/embedded (drones, robots). No customers, revenue, or timing disclosed.
- Army Vantage consolidation memo: official public Army directive to consolidate all organizations onto Vantage — the strongest platform-standardization evidence to date, and a concrete follow-on to last quarter's 10-year/$10B EA. No new dollars attached this quarter; the memo's revenue conversion mechanics (legacy sunsets → funded orders) are undisclosed.
- Maven: mentioned only in passing ("continued growth of Maven"); no usage-doubling update, no revenue run-rate, no NATO economics. NGC2 named as an opportunity. Golden Dome raised by an analyst; Sankar declined to comment specifically.
- Warp Speed: adoption claimed to be spreading from new defense entrants to the traditional defense industrial base and maritime industrial base — still no named new customers, revenue, or pricing.
- TITAN: not mentioned for the second consecutive quarter.
- FedStart: not mentioned for the third consecutive quarter.
- NHS/U.K.: international government +66% again attributed to "continued work in the U.K."; no NHS FDP metrics for the third straight quarter.
Sell-side read-through- Same two sell-side questioners for the sixth consecutive quarter: Wedbush (Ives) and BofA (Perez Mora); everything else pre-submitted shareholder questions. The call remains effectively unchallenged.
- Ives asked about accelerated sales cycles from boot camps — a soft question. Taylor's answer added useful data: U.S. commercial TCV $1.3B at >6x dollar-weighted duration, deal mix 83/40/21, and the pattern of customers arriving asking for enterprise-wide deployment. Karp added the "PE-like transformation in public markets" framing and noted newer clients have higher expectations (transform in months, in public).
- Perez Mora asked (1) what changed behaviorally in customers and internally (AI FDE adoption) — drew the headcount +10% vs revenue +63% disclosure, the most analytically useful answer of the call; (2) Golden Dome and government opportunities — Sankar declined specifics, named NGC2 and Maven growth, and cited U.S. involvement in "3 conflicts" (Europe, Middle East, "our own hemisphere") as demand context.
- Unchallenged again: AIP monetization/pricing (eleven quarters), FCF > CFO, Army EA economics (minimums, phasing, margins — now compounded by the Vantage memo), Maven revenue run-rate, Warp Speed revenue, TITAN (absent again), SBC forward run-rate, token buyback, RPO deceleration vs remaining-deal-value acceleration, and the absence of any international commercial breakdown behind the +10% print. Nobody asked how much of the Q4 guide is already de-risked by the $8.6B remaining deal value.
Management credibility- Beat-and-raise streak extends to eleven quarters, and the raises keep growing: ~1,300bps above the Q3 high end; FY revenue raised 8 points (+45% → +53%) after a 9-point raise the quarter before; U.S. commercial raised 19 points in 90 days (≥85% → ≥104%) after a 17-point raise the prior quarter.
- Delivered on the prior watchlist's key items: the Q3 hiring ramp did not dent margins (adjusted op margin 46% → 51%, GAAP 27% → 33% — H2 margin expansion claim held); U.S. commercial ex-SPAC accelerated again off the 95% print to 126%; U.S. government sustained ~+52–53%; international commercial turned positive (+10%) after three declines; NDR (134%), top-20 (+38%), remaining deal value (+91%) all accelerated again; no units errors in prepared remarks.
- Guidance posture: Q4 guide of +61% y/y / +13% q/q again embeds acceleration, but the FY raise ($252M) vs the Q3 beat (~$95M+ above high end) suggests Q4 guidance carries embedded upside — the setup remains demanding but not as fully drawn as the headline numbers imply.
- Debits: Karp's rhetoric escalated further ("best results any software company has ever delivered," extended political commentary on ICE/border/Israel unprompted in Q&A) — raises the cost of any future miss and adds governance/reputational risk that is entirely self-chosen; Army EA and Vantage memo economics still undisclosed; Maven went quiet (no usage or dollar update after last quarter's $795M ceiling); SBC forward run-rate still undisclosed and SBC ticked up to $172M; FCF > CFO unexplained for the eleventh-plus quarter; RPO growth decelerated while other forward indicators accelerated — unexplained.
- Consistency check: NDR (134%), top-20 (+38%), customer count (+45%), remaining deal value (+91%), TCV (+151%), and the headcount-vs-revenue disclosure all corroborate the acceleration and operating-leverage narrative. The one soft spot is RPO (+66% y/y, +8% q/q) lagging the other forward metrics.
What changed versus the prior quarter- Growth: total +48% → +63% (ex-SPAC +49% → +65%); U.S. commercial +93% → +121% headline, ex-SPAC +95% → +126%; U.S. government +53% → +52% (held the breakout); international commercial −3% → +10% y/y (inflected positive — resolves a three-quarter drag); international government +37% → +66% y/y (reaccelerated, U.K.-driven).
- Bookings: TCV $2.3B → $2.8B (+140% → +151% y/y); U.S. commercial TCV $843M → $1.3B (+222% → +342% y/y); remaining deal value +65% → +91%; RPO +77% → +66% y/y (decelerated — the one forward metric moving the other way); NDR 128% → 134%.
- Margins: AOI margin 46% → 51%; GAAP op margin 27% → 33%; GAAP net margin 33% → 40%; Rule of 40 94 → 114. OpEx +27% → +29% y/y — ramp continuing, margin expanding anyway.
- Guidance: FY revenue +45% → +53%; U.S. commercial ≥85% → ≥104%; AOI $1.912–1.920B → $2.151–2.155B; FCF $1.8–2.0B → $1.9–2.1B; FY Rule of 40 guide 91 → 102.
- Watchlist resolution vs prior packet: Q3 vs guide ✓ (beat by ~1,300bps, margins up through the hiring ramp); U.S. commercial ex-SPAC trajectory ✓ (126%, accelerated again); Army EA mechanics ✓ partially (Vantage consolidation memo — real standardization evidence, still no obligated minimums/phasing/margins); Maven revenue cadence ✗ (no update at all); U.S. government sustainability ✓ (+52%); international commercial ✓ (+10%, inflected); NDR/top-20 ✓ (both accelerated); AI FDE disclosure ✓ (production evidence + productivity metric); SBC run-rate ✗; AIP monetization ✗ (eleventh quarter); FCF vs CFO ✗ (persists); Warp Speed revenue/names ✗; TITAN ✗ (absent again).
Bull case- Acceleration is nine quarters deep and still steepening at scale: +63% on a $1.18B quarter, ex-SPAC +65%, with Q4 guided to +61% y/y and another highest-ever sequential guide — on a $4.4B run rate.
- U.S. commercial is compounding off its own acceleration: +121% y/y (+126% ex-SPAC), +29% q/q, TCV +342% with the first $1B+ bookings quarter, customers +65% — and the >8x ACV expansion in 5 months shows the land-and-expand motion operating at unprecedented speed and size.
- Forward cover is enormous: remaining deal value $8.6B (+91%), NDR 134%, TCV +151% — bookings continue to run far ahead of revenue, and the FY raise exceeding the Q3 beat implies Q4 is not fully drawn.
- Government standardization is converting to paper: the Army's official memo consolidating all organizations onto Vantage is the strongest platform-standard evidence yet, on top of the $10B EA ceiling, $795M Maven ceiling, and $218M Space Force order.
- Operating leverage is now quantified: headcount +10% vs revenue +63%, adjusted op margin 51%, GAAP op margin 33%, Rule of 40 at 114 with FY guided to 102 — AI FDE is the stated mechanism, giving the scalability claim its first hard internal data point.
- International commercial inflected positive (+10%) and international government reaccelerated (+66%) — the two prior soft spots both improved, reducing the concentration critique's bite at the margin.
Bear case- The bar is now extreme: Q4 guided to +61% y/y against the hardest comps of the cycle, FY Rule of 40 guided to 102 — expectations embedded in guidance leave almost no room for execution slippage, and management's own rhetoric ("best results ever delivered") removes any ability to frame a future deceleration as normal.
- Headline contract structures remain ceilings and directives, not revenue: the $10B Army EA, the Vantage consolidation memo, and the $795M Maven ceiling have no disclosed minimums, phasing, or margins — and Maven went from a dollar figure last quarter to no update at all this quarter.
- RPO decelerated (+77% → +66% y/y, +27% → +8% q/q) while every other forward metric accelerated — partly structural (government contracts excluded), but the divergence is unexplained and unexamined.
- Disclosure gaps are now eleven quarters deep on the most important questions: AIP pricing/monetization, Maven revenue run-rate, Warp Speed revenue, Army EA economics — the gap between narrative escalation and disclosed economics keeps widening.
- Accounting loose ends persist: FCF > CFO again, SBC up to $172M with no forward run-rate, buyback still token (~2.6M shares cumulative, $880M remaining).
- Self-inflicted risk is rising: Karp's extended political commentary (ICE, border, Israel) delivered unprompted on an earnings call creates customer, talent, and political-exposure risk that is entirely discretionary; the call remains analytically soft with the same two friendly questioners for six quarters.
Next-quarter watchlist- Q4 vs $1.327–1.331B revenue (+61% y/y, +13% q/q) and $695–699M AOI (~52% implied margin): does the guided Q4 expense increase dent margins, and does the FY Rule of 40 guide of 102 hold?
- U.S. commercial: ex-SPAC growth off the 126% print — comps now extreme; TCV against $1.3B; progress toward >$1.433B / ≥104% FY guide; customer adds from 530.
- Army Vantage memo conversion: first funded orders or revenue attributable to the consolidation directive; any disclosure of EA minimums, phasing, or margin treatment; pace of legacy-system sunsets.
- Maven: any revenue cadence, usage update, or COCOM/NGC2 awards after a silent quarter; Golden Dome exposure — Sankar declined to comment, watch for awards.
- U.S. government: sustainability of ~+52%; whether the "3 conflicts" demand context translates into named awards.
- International: does commercial +10% hold or re-deteriorate; any quantification of Europe vs Asia/Middle East; U.K.-driven government growth (+66%) concentration risk.
- RPO vs remaining deal value: does the divergence (RPO +66% vs RDV +91%) narrow or widen, and does management explain it?
- NDR from 134%; top-20 from +38%; U.S. commercial remaining deal value from +199%.
- AI FDE / AI Hivemind / Edge Ontology: any adoption counts, availability terms, or monetization; additional named re-platforming or migration proof points.
- SBC: forward run-rate disclosure; share count vs the token buyback.
- AIP monetization, eleven quarters overdue: pricing, paid-conversion, or revenue attribution.
- Cash: FCF vs CFO convergence; trajectory toward the raised $1.9–2.1B FCF guide.
- TITAN and FedStart: any mention after two and three absent quarters, respectively.
|
| Aug 4, 2025 | +7.85% | Q2 FY2025 | Read transcript briefingQuarter in one view- Revenue $1.004B, +48% y/y, +14% q/q — first $1B quarter, ~1,000bps above the high end of the $934–938M guide. Eighth consecutive acceleration quarter (+17% → +20% → +21% → +27% → +30% → +36% → +39% → +48%); Glazer frames it as a 2,100bps improvement vs Q2 last year's growth rate. Ex-strategic-contracts +49% y/y.
- U.S. revenue $733M, +68% y/y, +17% q/q — now 73% of the business (from 71%). U.S. commercial $306M, +93% y/y (+95% ex-SPAC), +20% q/q — 31% of Q2 revenue vs 23% a year ago. U.S. government $426M, +53% y/y, +14% q/q — accelerating from the +45% held for two quarters.
- Rule of 40 at 94 (from 83, +11pts q/q) — eighth consecutive quarter of expansion; FY Rule of 40 guided to 91. Adjusted operating margin 46% (from 44%), ~300bps above the high end of guide. GAAP operating income $269M (27% margin, from 20%). Adjusted FCF $569M (57% margin).
- Largest-ever guidance raise: FY2025 revenue to $4.142–4.150B (+45% midpoint, from +36% — a 9-point raise in one quarter); U.S. commercial to >$1.302B (≥85% growth, from ≥68% — a 17-point raise in 90 days); AOI to $1.912–1.920B; adjusted FCF to $1.8–2.0B. Q3: revenue $1.083–1.087B (+50% y/y, >8% q/q — highest-ever sequential guide), AOI $493–497M.
- Headline strategic items: 10-year Army enterprise agreement up to $10B consolidating 75 contracts into one; Maven Smart System ceiling raised $795M for expected combatant-command demand over 4 years; $218M Space Force delivery order; Maven usage doubled again since February (on top of the two prior doublings).
What management is focused on- Ontology as the moat, sharpened: Taylor now claims "LLMs simply don't work in the real world without Palantir" — LLMs are "jagged intelligence," ontology is "pure understanding, concretized in software." The model-commoditization framing persists but the rhetoric has escalated from "we capture the value" to "we are the prerequisite."
- New strategic theme — AIP as a platform others build on: Sankar introduces "Ontology web services" as an architectural concept; software companies are "re-platforming away from the highly unopinionated hyperscaler stack onto AIP." Named proof: TeleTracking (Co-CEO Chris Johnson) re-platformed on AIP and was "flooded with inquiries" after going public. Framed as a significant roadmap investment and growth opportunity across commercial and government.
- AI FDE (forward deployed engineer) as a product: autonomous execution across ontology creation/editing, data transforms, functions, debugging, application building, with closed-loop error handling and human-in-the-loop branching. Positioned as accelerating time-to-value and letting customers solve bigger problems independently — i.e., productizing the FDE motion that skeptics called unscalable.
- Blue-collar/AI-agency narrative: Karp and Sankar lean hard into "AI giving American workers superpowers" — ICU nurses, submarine-industrial-base factory workers (3 days of quoting reclaimed), Panasonic Energy battery technicians trained via AI; new "American Tech Fellowship" to credential non-traditional workers; Karp plans outreach to labor leaders on "AI-enhanced earnings." This is both a market narrative and a talent/positioning strategy.
- Customer-voice strategy continues and upgrades: Citi (KYC onboarding 9 days → seconds), Fannie Mae (mortgage fraud detection 2 months → seconds), Nebraska Medicine (2,100% discharge-lounge utilization increase; "a Palantir unit of time" = value in under an hour), Lear (5-year extension; 11,000 users, 175+ use cases over 2.5 years including tariff-exposure management; CEO claims hard-to-replicate first-mover advantage).
- Conversion-speed anecdotes with bigger dollars: healthcare company boot camp in April → $88M TCV deal one month later; American telecom (started 2022) expanded contract 10x and projects hundreds of millions in cost savings.
- Government demand framed as structural: Army EA consolidating 75 contracts; Maven ceiling raise explicitly tied to expected COCOM demand; Sankar says Maven "met its moment in recent operations of great import" (unnamed). U.S. shipbuilding flagged as a "dramatic set of opportunities" for Warp Speed ("China built more ships last year than we have built cumulatively since WWII").
- Karp's rhetoric: back to full volume after last quarter's moderation — "once in a generation truly anomalous quarter," "sorry that our haters are disappointed… many more quarters to be disappointed," taunting analysts "wrong about every quarter," and a "10x revenue in the U.S. over the next 5 years" personal view (explicitly his view, not a forecast). Also a notable claim: "people with less than a college education are creating… sometimes more value than people with a college education using our product" inside the U.S. government.
Key numbers and quarter mechanics- Segments: commercial $451M (+47% y/y, +14% q/q; +49% ex-SPAC); government $553M (+49% y/y, +14% q/q). U.S. commercial $306M (+93%/+95% ex-SPAC, +20% q/q); international commercial $144M (−3% y/y, +2% q/q — third quarter of y/y decline, though the rate improved from −5%); U.S. government $426M (+53%, +14% q/q); international government $127M (+37% y/y, +11% q/q — decelerated from +45%, "bolstered primarily by continued work in the U.K.").
- Customer count 849, +43% y/y, +10% q/q. U.S. commercial customers 485, +64% y/y, +12% q/q (from 432). Top-20 customers $75M TTM each, +30% y/y — fourth consecutive acceleration (+12% → +18% → +26% → +30%).
- Bookings: record TCV $2.3B, +140% y/y (eclipsing the prior Q4 2024 record by ~$0.5B); record ACV $684M. 157 deals ≥$1M, 66 ≥$5M, 42 ≥$10M. Commercial TCV $1.1B, +185% y/y; U.S. commercial TCV $843M, +222% y/y; trailing-12-month U.S. commercial TCV $2.8B, +141%. U.S. commercial remaining deal value +145% y/y, +20% q/q.
- Total remaining deal value $7.1B, +65% y/y, +20% q/q (from $5.97B). RPO $2.4B, +77% y/y, +27% q/q (from $1.9B) — reaccelerating sharply. NDR 128%, +400bps q/q (124% → 128%), with the standard caveat that it excludes customers acquired in the past 12 months; Glazer notes the increase came from both expansions and the Q2-2024 cohort seasoning in.
- Margins: adjusted gross margin 82% (flat); adjusted op margin 46% (from 44%); adjusted OpEx $539M, +9% q/q, +27% y/y (AIP and technical hiring). Management guides to H2 margin expansion but repeats a "significant ramp in expenses in Q3 due to seasonality of new hire starts."
- GAAP: operating income $269M (27% margin, from 20%); net income $327M (33%); GAAP EPS $0.13; adjusted EPS $0.16. SBC $160M plus $35M employer equity taxes (from $155M/$59M) — SBC stable, taxes down; forward run-rate still not guided.
- Cash: CFO $539M (54%), adjusted FCF $569M (57%) — FCF > CFO quirk persists. Cash/T-bills $6.0B (from $5.4B). Buyback ~2.5M shares cumulative (from ~2.3M); $899M remaining — still token against $160M quarterly SBC.
- Strategic commercial contracts: $5.1M revenue in Q2; Q3 guided to $2–4M vs $10M in Q3 2024; FY2025 expected <0.5% of revenue — the SPAC drag is nearly fully lapped out.
- Guidance math: Q3 guide implies +50% y/y and >8% q/q — acceleration guided, not deceleration. FY midpoint +45% vs H1 actuals (+39%, +48%) implies H2 ~+47% — the guide now embeds sustained acceleration, a shift from last quarter's implied deceleration.
- Transcript quirks: Glazer says "surpassing $1 million of revenue in the quarter" (clearly means $1 billion); Glazer says "RPU" when describing RPO; Karp says "oncology" when he means ontology; Taylor says bookings were booked "last quarter" while describing Q2 figures. None alter the substance, but the $1M/$1B slip is the second consecutive quarter with a units error in prepared remarks.
Product and launch scorecard- AIP (~2.5 years): strongest quarter yet — U.S. commercial +93%, TCV +222%, NDR 128%, $88M TCV one-month conversion, 42 deals ≥$10M. New platform claim (re-platforming onto AIP, TeleTracking named) extends AIP from application to infrastructure. Still missing: pricing model, paid-conversion rate, AIP revenue attribution — now ten quarters.
- AI FDE: first detailed disclosure — autonomous ontology editing, transforms, debugging, app building, closed-loop error handling, human-in-the-loop branching. Strategically important (productizes the FDE bottleneck) but no adoption, revenue, or availability metrics.
- Maven: economics finally attached — ceiling raised $795M (4-year expected COCOM demand), on top of last quarter's NATO adoption; usage doubled again since February (third disclosed doubling). Still no revenue run-rate, but the ceiling raise is the first hard dollar figure on Maven demand.
- Army enterprise agreement: 10 years, up to $10B, consolidating 75 contracts — the largest single contract disclosure in company history per the call. Note: "up to" ceiling language; no obligated minimums, revenue phasing, or margin terms disclosed.
- Space Force: $218M delivery order (Space Systems Command) for multi-domain space/air operations — a concrete, funded award.
- Warp Speed: new vertical claimed — U.S. shipbuilding ("dramatic set of opportunities"); MRP Speed anecdote (line balancing 1 day → 1 hour); customers "from nuclear companies to the defense industrial base." Still no named new customers, revenue, or pricing.
- TITAN: not mentioned this quarter after last quarter's delivery milestone — no follow-on orders or economics.
- FedStart: not mentioned for the second consecutive quarter.
- NHS/U.K.: international government +37% attributed to "continued work in the U.K."; no NHS FDP metrics for the second straight quarter.
Sell-side read-through- Same two sell-side questioners for the fifth consecutive quarter: Wedbush (Ives) and BofA (Perez Mora); everything else was pre-submitted shareholder questions read by IR. The call remains effectively unchallenged.
- Ives asked whether Palantir will build a direct sales force given growth — a soft question. Karp's answer is strategically substantive: the primary sales force is "current customers telling other customers," credibility lets them "use more of our product on day 1," and employee churn across enterprises seeds new accounts ("I got blocked at my last enterprise… first call was to us"). Taylor adds customers now ask upfront "how do we roll this across the whole enterprise." Karp also floated "10x revenue in the U.S. over the next 5 years" as his personal view — an unguided, unchallenged number that will get quoted.
- Perez Mora asked (1) about the White House AI Action Plan — Sankar: "taking all the brakes off," endorsement of an American open AI tech stack, implies follow-on government investment; (2) talent retention amid the industry talent war — Sankar: retention "quite strong," differentiator is access to problems that matter; Karp: Palantir is "by far the best credential in tech," time-to-agency ~3 months. Neither question touched financials.
- Unchallenged again: AIP monetization/pricing (ten quarters), FCF > CFO, Army EA economics (minimums, phasing, margins), Maven revenue run-rate, Warp Speed revenue, TITAN (absent entirely), international commercial's third straight y/y decline, SBC forward run-rate, and the token buyback. Nobody asked about the Q3 expense ramp vs the guided H2 margin expansion, or how much of the $10B Army ceiling is realistically convertible.
Management credibility- Beat-and-raise streak extends to ten quarters, and the raises are getting larger: ~1,000bps above the Q2 high end; FY revenue raised 9 points in one quarter (+36% → +45%) after a 5-point raise the quarter before; U.S. commercial raised 17 points in 90 days (≥68% → ≥85%) after a 14-point raise the prior quarter. "Largest ever full year revenue guidance raise."
- Delivered on the prior watchlist's key items: the implied-H2-deceleration concern was resolved decisively (Q3 guided to +50% y/y, FY to +45%); U.S. commercial ex-SPAC accelerated off the 75% peak (95%) rather than fading; adjusted op margin expanded to 46% despite the expense ramp; GAAP op margin jumped to 27%; Maven got its first dollar figure ($795M ceiling); U.S. commercial customer adds strong (432 → 485).
- Guidance posture flipped from conservative-embedding-deceleration to embedding-acceleration — credibility now rests on H2 delivery of ~+47% growth, a higher bar than the prior setup.
- Debits: Karp's "10x U.S. revenue in 5 years" is an unguided personal view delivered on an earnings call — the kind of number that can be weaponized later; the Army "$10B" is a ceiling, not committed revenue, and management did nothing to temper that distinction; international commercial declined for the third straight quarter with no quantification of the Europe drag; SBC forward run-rate still undisclosed; FCF > CFO unexplained for the tenth-plus quarter; second consecutive quarter with a units slip in prepared remarks ($1M vs $1B).
- Consistency check: NDR (128%), top-20 (+30%), customer count (+43%), RPO (+77%), and remaining deal value (+65%) all corroborate the acceleration narrative — the quality metrics are moving with revenue, not against it.
What changed versus the prior quarter- Growth: total +39% → +48% (ex-SPAC +44% → +49%); U.S. commercial +71% → +93% headline, ex-SPAC +75% → +95% (reaccelerated off the peak — the biggest surprise of the quarter); U.S. government +45% → +53% (broke out of the two-quarter hold); international commercial −5% → −3% y/y, −11% → +2% q/q (still shrinking, rate improving); international government +45% → +37% y/y (decelerated).
- Bookings: TCV $1.5B → $2.3B (+66% → +140% y/y); U.S. commercial TCV $810M → $843M (+239% → +222% y/y); remaining deal value +45% → +65%; RPO +46% → +77%; NDR 124% → 128%.
- Margins: AOI margin 44% → 46%; GAAP op margin 20% → 27%; Rule of 40 83 → 94. OpEx +21% → +27% y/y — ramp continuing, margin expanding anyway.
- Guidance: FY revenue +36% → +45%; U.S. commercial ≥68% → ≥85%; AOI $1.711–1.723B → $1.912–1.920B; FCF $1.6–1.8B → $1.8–2.0B; new FY Rule of 40 guide of 91.
- Watchlist resolution vs prior packet: Q2 vs guide ✓ (massive beat, margin up not down); U.S. commercial ex-SPAC trajectory ✓ (95%, reaccelerated); Maven economics ✓ partially ($795M ceiling — first dollars, still no revenue run-rate); NATO contract value ✗ (no separate disclosure; may be inside Maven ceiling); TITAN follow-on ✗ (not mentioned); international commercial ✗ (still negative, no Europe quantification); NDR/top-20/RPO ✓ (all accelerated); SBC run-rate ✗; AIP monetization ✗ (tenth quarter); FCF vs CFO ✗ (persists); Warp Speed revenue/names ✗ (shipbuilding vertical claimed, no names or dollars); FCF guide cleanliness ✓ (raised to $1.8–2.0B, no unit errors this quarter).
Bull case- Acceleration is eight quarters deep and steepening at scale: +48% on a $1B quarter, ex-SPAC +49%, with Q3 guided to +50% y/y and the highest sequential guide ever — the law of large numbers is being defied on a $4B+ run rate.
- U.S. commercial reaccelerated off its peak: +93% y/y (+95% ex-SPAC) vs +75% ex-SPAC last quarter, +20% q/q, TCV +222%, customers +64% — the hardest-comp quarter produced the fastest growth, invalidating the deceleration thesis.
- Bookings are running far ahead of revenue: TCV +140%, RPO +77%, remaining deal value +65%, NDR 128% — a large forward revenue cushion is now on the books.
- Government converted narrative to paper this quarter: $10B Army EA ceiling (75 contracts consolidated — reduces recompete risk), $795M Maven ceiling raise tied to named demand, $218M Space Force order. The platform-standard claims now have contract vehicles attached.
- Profitability is expanding with growth, not despite it: Rule of 40 at 94, GAAP op margin 27%, adjusted margin 46% and guided to expand in H2 even with the Q3 hiring ramp — the "invest and expand margins" claim keeps being delivered.
- The sales model is showing operating leverage: no direct sales force build, customer-led selling, and Karp's credibility argument is corroborated by deal velocity (157 ≥$1M deals, one-month $88M conversion).
Bear case- The guide now embeds acceleration, not conservatism: FY +45% requires ~+47% in H2 against the hardest comps of the cycle; the margin for positive surprise is structurally thinner than in prior quarters.
- Headline contract numbers are ceilings, not revenue: the $10B Army EA and $795M Maven raise are capacity, not obligations; no minimums, phasing, or margins were disclosed, and no analyst asked.
- International commercial has now declined y/y for three consecutive quarters (−3% after −5%); the growth story is 73% American and concentration keeps rising, with management offering no Europe fix beyond "targeted opportunities in Asia, the Middle East."
- Karp's unguided "10x U.S. revenue in 5 years" and "haters will be disappointed" rhetoric raise the stakes of any future miss; the gap between management's exuberance and disclosed economics (AIP pricing, Maven revenue, Warp Speed revenue — all still absent after ten quarters) remains the core analytical risk.
- Accounting loose ends persist: FCF > CFO again, buyback still token (~2.5M shares cumulative, $899M remaining) against $160M quarterly SBC, forward SBC undisclosed, and a second straight quarter with a units error in prepared remarks.
- The call remains analytically soft: same two friendly questioners for five quarters, zero financial scrutiny in Q&A, and the most consequential disclosures (Army EA structure, Maven ceiling mechanics) went entirely unexamined.
Next-quarter watchlist- Q3 vs $1.083–1.087B revenue (+50% y/y) and $493–497M AOI (~45.5% implied margin): does the guided Q3 hiring ramp (OpEx seasonality) dent margins, and does management's claim of H2 margin expansion hold?
- U.S. commercial: ex-SPAC growth off the 95% print — comps now extremely hard; TCV against $843M; progress toward >$1.302B / ≥85% FY guide; customer adds from 485.
- Army EA mechanics: first revenue under the consolidated vehicle, any disclosure of obligated minimums, phasing, or margin treatment; whether the $10B ceiling starts converting to funded orders.
- Maven: revenue cadence against the raised $795M ceiling; any COCOM-specific awards; whether NATO economics ever get separately disclosed.
- U.S. government: sustainability of +53%; any DOGE-related timing lumpiness (Karp's prior hedge, unmentioned this quarter).
- International commercial: does −3% y/y turn positive or re-deteriorate; any quantification of Europe; Warp Speed shipbuilding wins with named customers or dollars.
- NDR from 128%; top-20 from +30%; RPO/remaining-deal-value trajectory against hardened comps.
- AI FDE: availability, adoption, or monetization disclosure; whether the re-platforming thesis (TeleTracking) gains additional named proof points.
- SBC: forward run-rate disclosure; share count vs the token buyback.
- AIP monetization, ten quarters overdue: pricing, paid-conversion, or revenue attribution.
- Cash: FCF vs CFO convergence; trajectory toward the raised $1.8–2.0B FCF guide.
- TITAN: any follow-on orders or economics after going unmentioned this quarter.
|
| May 5, 2025 | -12.05% | Q1 FY2025 | Read transcript briefingQuarter in one view- Revenue $884M, +39% y/y, +7% q/q — beat the high end of the $858–862M guide by ~350bps. Seventh consecutive acceleration quarter (+17% → +20% → +21% → +27% → +30% → +36% → +39%); ex-strategic-contracts +44% y/y. Glazer frames it as an 1,800bps improvement vs Q1 last year's growth rate.
- U.S. revenue $628M, +55% y/y, +13% q/q — now 71% of the business. U.S. commercial $255M, +71% y/y (+75% ex-SPAC), +19% q/q, crossing a $1B annual run rate for the first time; U.S. commercial TCV $810M, +239% y/y on a dollar-weighted duration basis; twice as many ≥$1M deals as a year ago. U.S. government +45% y/y, +9% q/q — holding the Q4 rate.
- Rule of 40 at 83 (from 81). Adjusted operating margin 44% (+800bps y/y; down 1pt q/q from the record 45%). Adjusted FCF $370M (42% margin). GAAP operating income $176M (20% margin) — a clean GAAP quarter with no SAR-type distortion disclosed.
- Guidance raised again: FY2025 revenue to $3.89–3.902B (+36% midpoint, from +31%); U.S. commercial to >$1.178B (≥68% growth, from ≥54%); adjusted op income to $1.711–1.723B; adjusted FCF to $1.6–1.8B. Q2: revenue $934–938M, AOI $401–405M.
- Headline strategic items: first TITAN vehicles delivered to the Army "on time, on budget" and rated a top-performing program; NATO adopted Maven Smart System as its C2 operating system across 32 member states; named customer proof points now appearing on customers' own earnings calls (AIG, Citi, BP, L3Harris, Hertz, Walgreens).
What management is focused on- Enterprise autonomy as the demand-side thesis, continued from Q4: Sankar reiterates "not copilots that make you 50% more productive… agents that make you 50 times more productive," with ontology as the "common intermediary representation" for mixed human/AI teams. New agent examples: AIG's AI underwriting agent, DoD intelligence-report processing "finding things humans missed," sepsis monitoring at Tampa General.
- Model commoditization victory lap continues: "blindingly obvious to everyone after the first DeepSeek moment" — the supply-side/demand-side framing is now standard script.
- Customer-voice strategy: management repeatedly deflects proof to customers' own earnings calls (AIG, Citi, BP, L3Harris, Hertz) — a deliberate shift from Palantir asserting value to customers asserting it. AIG quote: Palantir expected to double its five-year CAGR; underwriting data in 2–3 hours vs weeks. Walgreens: AI workflows in 4,000 stores in eight months, "384 billion decisions every day" automated.
- Conversion-speed anecdotes with dollar figures: healthcare company boot camp in December → five-year, $26M ACV enterprise agreement five weeks later; global bank pilot in Q4 2024 → $2M engagement → three-year, $19M ACV four months later; Fortune 500 healthcare (started Q2 2024) → five-year, $10M ACV conversion.
- New named partnership: R1 RCM for healthcare reimbursement automation, with the customer citing a "multi-$100 billion opportunity."
- Government: DOGE/efficiency pressure embraced again — Sankar calls DOGE staff "heroes… world-class technologists" and legacy spend "finely marbled wagyu"; Karp: "Palantir does exceptionally well when things are pentested." Maven demand "very significant… both in America and outside of America."
- TITAN reframed as cultural proof: "everything about it is heretical — a military vehicle with a software company as prime," built with Anduril.
- Karp's rhetoric: somewhat moderated in tone versus Q4 ("admonished to be a little more modest") but still "unfair advantage to the noble warriors of the West" and "on occasion hurting" enemies; Europe still dismissed ("doesn't get AI yet"), with ex-Continental-Europe business (90% of revenue) cited at +49% growth.
Key numbers and quarter mechanics- Segments: commercial $397M (+33% y/y, +7% q/q; +42% ex-SPAC); government $487M (+45% y/y, +7% q/q). U.S. commercial $255M (+71%/+75% ex-SPAC, +19% q/q); international commercial $141M (−5% y/y, −11% q/q — Europe headwinds plus lapping the Q4 one-time revenue catch-up); U.S. government $373M (+45%, +9% q/q); international government $114M (+45% y/y, +2% q/q — U.K. healthcare/defense, new NATO partnership).
- Customer count 769, +39% y/y, +8% q/q. Top-20 customers $70M TTM each, +26% y/y — third consecutive acceleration (+12% → +18% → +26%).
- Bookings: total TCV $1.5B, +66% y/y; commercial TCV $930M, +84% y/y; U.S. commercial TCV $810M, +239% y/y dollar-weighted-duration basis. Total remaining deal value $5.97B, +45% y/y, +10% q/q; RPO $1.9B, +46% y/y, +10% q/q. NDR 124%, +400bps q/q (120% → 124%), with the standard caveat that it excludes customers acquired in the past 12 months.
- Margins: adjusted gross margin 82% (from 83%); adjusted op margin 44% (from 45%); adjusted OpEx $493M, +8% q/q, +21% y/y — the guided 2025 expense ramp (AIP, technical hiring) is now visible in the numbers. Management repeats that a "more significant increase in expense" is coming in 2025.
- GAAP: operating income $176M (20% margin); net income $214M (24% margin); GAAP EPS $0.08; adjusted EPS $0.13. SBC $155M plus $59M employer equity taxes — down sharply from Q4's $282M/$80M, consistent with the SAR acceleration being one-time, but forward run-rate still not explicitly guided.
- Cash: CFO $310M (35%), adjusted FCF $370M (42%) — FCF > CFO quirk persists. Cash/T-bills $5.4B (from $5.2B). Buyback ~2.3M shares cumulative (from ~2.1M); $918M remaining — still token.
- Guidance math: Q2 guide $934–938M implies ~+5.7–6.1% q/q and ~+38% y/y; FY midpoint +36% vs Q1 actual +39% — implies some deceleration through the year, though the guide has been raised twice in two quarters. U.S. commercial guide ≥68% vs Q1 actual +71%.
- Transcript quirks: Taylor says rule of 40 "increasing from 81% in Q4 to 83% last quarter" (means this quarter); Karp cites "71% growth in US commercial" twice while prepared remarks also say 71% — internally consistent, but his "49% ex-Continental Europe" figure is not reconciled to any disclosed segment number.
Product and launch scorecard- AIP (~2 years): strongest conversion evidence yet — three named-dollar conversion stories with timelines (5 weeks to $26M ACV; pilot → $19M ACV in ~5 months; $10M ACV conversion), U.S. commercial TCV +239%, NDR 124%, $1B run rate crossed. Still missing: pricing model, paid-conversion rate, AIP revenue attribution — now nine quarters.
- Maven: biggest quarter of disclosures — NATO selected Maven Smart System as its C2 operating system across 32 member states; usage doubled in the first nine months of 2024 and doubled again in the following five months; EUCOM quote ("decision advantage environment"); combatant commanders citing Maven in congressional posture hearings. Still no ceiling, contract value, or revenue figures.
- TITAN: resolved the prior quarter's silence — first vehicles delivered to the Army in Q1, "on time, on budget," rated a top-performing Army program; Anduril named as part of the team. No economics, unit counts, or margin treatment disclosed.
- Warp Speed: adoption and product development "exceeded expectations"; Sankar claims traction with new defense entrants, traditional defense primes, and broader manufacturing; European manufacturers showing "green shoots" of interest. No new named customers beyond the Anduril/L3Harris cohort, no revenue or pricing.
- FedStart: not mentioned this quarter after the Q4 FedRAMP High milestone.
- NHS/U.K.: international government +45% y/y attributed to U.K. healthcare and defense plus NATO; no NHS FDP metrics updated this quarter.
- Software-defined hardware thesis: Sankar extends the TITAN logic to classified programs ("build the mission payload and software first, then wrap hardware around it") — a strategic claim about future program wins, currently unquantified.
Sell-side read-through- Only two sell-side questioners again: Wedbush (Ives) and BofA (Perez Mora) — fourth consecutive quarter with the same narrow institutional bench. The rest of Q&A was pre-submitted shareholder questions read by IR.
- Ives asked whether DOGE-style budget pressure lets Palantir gain share within DoD/agency budgets — a leading question Karp answered with optimism plus a "devil's in the details… maybe lumpiness" hedge, the only cautionary language on government in the call.
- BofA's Perez Mora asked the two most substantive questions: (1) European defense buildup — Sankar: "would love to help," precondition is customers recognizing their manufacturing stack is broken; short sales cycles with new champions, heterogeneous with incumbents; Karp: Europe "doesn't get AI yet," could take "a couple of years." (2) Where software-first hardware applies beyond TITAN (Golden Dome, space comms?) — Sankar pointed to classified programs using software-first design; no specific program confirmed.
- Pre-submitted questions covered AI competitive advantage (Sankar: ontology as demand-side moat, mixed human-AI teams) and DOGE impact on contracts (embraced, again).
- Unchallenged again: AIP monetization/pricing (nine quarters), FCF > CFO, Maven contract economics, Warp Speed revenue, TITAN economics despite delivery, international commercial decline, and the lack of any question on the FY guide's implied second-half deceleration. No analyst pressed on anything; the call remains effectively unchallenged.
Management credibility- Beat-and-raise streak extends to nine quarters: revenue ~350bps above the high end; FY guide raised from +31% to +36% after being set at +31% only one quarter ago; U.S. commercial guide raised from ≥54% to ≥68% — a 14-point raise in 90 days.
- Delivered on the prior watchlist's biggest items: TITAN reappeared with a concrete delivery milestone (on time, on budget, top-rated); the 2025 expense ramp showed up as guided (OpEx +21% y/y) while margin held at 44%; GAAP op margin recovered to 20% — above the 17% ex-SAR Q4 level — validating the "SAR was one-time" implication.
- NDR (124%), top-20 (+26%), and customer count (+39%) all corroborate the expansion narrative; the conversion anecdotes now carry dollar figures and timelines, an improvement in specificity.
- Debits: international commercial declined (−5% y/y) and the explanation (Europe + lapping the Q4 catch-up) confirms the prior quarter's q/q strength was partly mechanical; Karp's "49% ex-Continental Europe" and "rule of 83" framing mixes disclosed and undisclosed cuts of the business; Maven's NATO win has no attached economics; forward SBC run-rate still undisclosed; the Q4 FCF guide typo was never addressed on either call.
- Guidance credibility remains the core asset — but note the FY midpoint (+36%) now sits below Q1 actual (+39%), so the raise still embeds deceleration; whether that is conservatism or visibility will be tested in H2.
What changed versus the prior quarter- Growth: total +36% → +39% (ex-SPAC +39% → +44%); U.S. commercial +64% → +71% headline, ex-SPAC +76% → +75% (held near peak); U.S. government +45% → +45% (sustained); international commercial +3% → −5% y/y, +15% → −11% q/q (Asia catch-up lapped; Europe deteriorating); international government +28% → +45% y/y (U.K. + NATO).
- Bookings: total TCV +56% → +66% y/y ($1.79B → $1.5B — Q1 is seasonally smaller); commercial TCV +42% → +84% y/y; remaining deal value +40% → +45%; RPO +39% → +46% (reaccelerated); NDR 120% → 124%.
- Margins: AOI margin 45% → 44% (expense ramp beginning); adjusted gross margin 83% → 82%; GAAP op margin 1% (17% ex-SAR) → 20% clean.
- Guidance: FY revenue +31% → +36%; U.S. commercial ≥54% → ≥68%; AOI $1.551–1.567B → $1.711–1.723B; FCF $1.5–1.7B → $1.6–1.8B.
- Watchlist resolution vs prior packet: expense ramp visible with margin held ✓; U.S. commercial ex-SPAC trajectory ✓ (75%, near-peak held); GAAP op margin recovery ✓ (20%); TITAN ✓ (first delivery, top-rated); Maven expansion ✓ (NATO, usage doubling); SBC forward run-rate ✗ (Q4 spike confirmed one-time in practice, but no guidance); AIP monetization ✗ (ninth quarter); FCF vs CFO convergence ✗ (persists); Warp Speed new names/revenue ✗; NHS economics ✗ (not updated); FCF typo confirmation ✗ (never addressed).
Bull case- Acceleration is seven quarters deep and still steepening: +39% on a ~$3.5B run-rate base, ex-SPAC +44%, with the FY guide raised to +36% one quarter after being set at +31% — management is chasing reality upward, not guiding down into strength.
- U.S. commercial is compounding at scale: +71% y/y, +19% q/q in the seasonally slowest quarter, $1B run rate crossed, TCV +239%, and conversion anecdotes now carry five-to-eight-figure ACVs with weeks-long timelines — the land-and-expand machine is producing dollar-denominated proof.
- Quality metrics all accelerated simultaneously: NDR 124% (+400bps), top-20 +26% (third straight acceleration), RPO +46% (reaccelerated), remaining deal value +45% — bookings and expansion are running ahead of revenue.
- The government moat widened structurally this quarter: NATO adopting Maven as its C2 standard across 32 states is a platform-standard event, not a contract win; TITAN's on-time, on-budget, top-rated delivery validates the software-prime model and the software-first hardware doctrine Sankar is now extending to classified programs.
- GAAP profitability proved durable without adjustment games: 20% GAAP op margin in a clean quarter, Rule of 83, and the guided expense ramp is being absorbed while margins hold — the "invest and expand profitability" claim continues to be delivered.
- Customers are now making the case on their own earnings calls (AIG's doubled-CAGR claim, Citi, BP, L3Harris, Hertz) — third-party validation reduces reliance on Palantir's own narrative.
Bear case- The FY guide implies deceleration: Q1 printed +39% against a +36% FY midpoint, and U.S. commercial guided ≥68% vs +71% actual — comps get harder each quarter and the raise may reflect Q1 outperformance annualized rather than H2 acceleration.
- International commercial is now shrinking: −5% y/y, −11% q/q, with management confirming Europe is structurally weak ("doesn't get AI yet," "a couple of years") — the growth story is now 71% American and concentration risk is rising, not falling.
- The biggest strategic wins carry no economics: NATO Maven, TITAN delivery, Warp Speed traction — none have disclosed contract values, margins, or revenue timing; investors are underwriting platform narratives without P&L visibility.
- Government growth durability is untested against DOGE: management asserts efficiency pressure is a tailwind, but Karp himself hedged ("devil's in the details… maybe lumpiness"), and no analyst challenged the assumption that budget cuts net positive for Palantir.
- Accounting loose ends persist: FCF > CFO again, buyback still token (~2.3M shares cumulative) against $155M quarterly SBC, forward SBC run-rate undisclosed, and the Q4 FCF guide typo never corrected on the record.
- The call remains analytically soft: same two friendly questioners, no challenge on AIP pricing (nine quarters), no scrutiny of the implied H2 deceleration, and management's undisclosed cuts of the business ("49% ex-Continental Europe") can't be tied to reported segments.
Next-quarter watchlist- Q2 vs $934–938M revenue and $401–405M AOI (~43% implied margin): does the expense ramp push adjusted op margin below 44%, and does GAAP op margin hold near 20%?
- U.S. commercial: ex-SPAC growth off the 75% peak as AIP comps get hardest; TCV against the $810M print; progress toward the >$1.178B / ≥68% FY guide; customer adds from 432.
- U.S. government: any DOGE-related award timing disruption or "lumpiness" Karp flagged; Maven revenue cadence post-NATO; whether the NATO deal gets a contract value, ceiling, or revenue start date.
- TITAN: follow-on orders, unit economics, or margin treatment now that vehicles are delivered; any software-first hardware program wins (Golden Dome or classified) becoming public.
- International commercial: does −5% y/y worsen, and does management quantify Europe's drag; any Warp Speed wins with European manufacturers ("green shoots").
- NDR from 124%; top-20 growth from +26%; RPO/remaining-deal-value trajectory as bookings comps harden.
- SBC: forward run-rate disclosure; share count trajectory against the token buyback ($918M remaining).
- AIP monetization, nine quarters overdue: pricing, paid-conversion, or revenue attribution.
- Cash: FCF vs CFO convergence; confirmation the raised $1.6–1.8B FCF guide is clean (no unit errors).
- Warp Speed: new named customers beyond Anduril/L3Harris, first revenue or pricing disclosure.
|
| Feb 3, 2025 | +23.99% | Q4 FY2024 | Read transcript briefingQuarter in one view- Revenue $828M, +36% y/y, +14% q/q — beat the high end of the $767–771M guide by >900bps; ex-strategic-contracts +39% y/y. Sixth consecutive acceleration quarter (+17% → +20% → +21% → +27% → +30% → +36%). FY2024 revenue $2.87B, +29%.
- U.S. business +52% y/y, +12% q/q. U.S. commercial $214M, +64% y/y (+76% ex-SPAC), +20% q/q; customer count 382, +73% y/y; U.S. commercial TCV $803M, +134% y/y, +170% q/q — nearly $400M above the prior best quarter; U.S. commercial remaining deal value +99% y/y. U.S. government $343M, +45% y/y, +7% q/q — the feared year-end hangover did not materialize.
- Rule of 40 at 81 (+13pts q/q from 68). AOI $373M (45% margin — company record). GAAP distorted by a $131M one-time SAR acceleration: GAAP operating income $11M (1%), or $142M (17%) ex-SAR; GAAP net income $79M (10%), or $165M (20%) ex-SAR.
- Cash: CFO $460M (56%), adjusted FCF $517M (63%); FY adjusted FCF $1.25B (44%). Cash/T-bills $5.2B (from $4.6B).
- Guidance raised massively: FY2025 revenue $3.741–3.757B (+31% midpoint) vs FY2024 actual +29%; U.S. commercial >$1.079B (≥54% growth — same growth rate as FY2024 actual); AOI $1.551–1.567B (~41% implied margin); adjusted FCF $1.5–1.7B (transcript reads "$1.7 million" — almost certainly a transcription error for billion; verify against press release); GAAP operating and net income positive in every quarter of 2025. Q1: revenue $858–862M, AOI $354–358M.
What management is focused on- DeepSeek-R1 as vindication: Sankar explicitly claims the model-commoditization thesis ("converging models, inference price dropping like a rock") has moved "from a contrarian position to consensus." He also escalates the China framing — "we are at war with China… an AI arms race" — while crediting R1's engineering as "exquisite" and warning against the "facile explanation that the Chinese just copy."
- "Quantified exceptionalism" and the self-driving company: the new demand-side frame is enterprise autonomy — users supervising "an army of agents." New proof points: multinational bank back-office process five days → three minutes; engineering/construction firm risk review of tens of thousands of pages months → minutes; automotive supplier CAD validation, a 100-hour human process now automated with exception review; power systems company technical diagrams → quotes → orders.
- Named expansion deals as evidence: pharmacy customer (since early 2024) signed $67M TCV right after pilot; telecom signed $40M TCV expansion for network decommissioning; the insurer from last quarter's 2-weeks→3-hours story signed a ~$11M ACV expansion; Panasonic Energy maintenance assistant supporting 350 technicians / 5.5M batteries per day.
- Warp Speed first cohort named: Anduril and L3Harris, with an Anduril CIO quote claiming "up to 200 times efficiency gained" in anticipating supply shortages. Pipeline described as "swelling."
- Maven broadening: contested logistics integrated into the kill chain and exercised in Q4; adoption across Army, Air Force, Space Force and combatant commands (SPACECOM, SOUTHCOM, AFRICOM, STRATCOM); Hurricane Helene drove unclassified-network adoption; new use cases in border security and drone domain awareness; MAVEN REL for allies.
- FedStart milestone: FedRAMP High environment approved for FedStart customers — pitched as radical time/cost reduction for software companies entering the federal market.
- DOGE as opportunity: Sankar frames Palantir's real government competition as "a lack of accountability" and legacy system integrators (D6A cited as a multi-billion-dollar failure), arguing efficiency-driven disruption favors Palantir's meritocratic, commercial-style delivery. Karp: "We love disruption."
- Karp's monologue: victory lap on the ontology bet, Europe dismissed as "anemic" (~4% growth on 13% of revenue), "making America more lethal," and a closing line to retail investors about scaring and "on occasion kill[ing]" enemies.
Key numbers and quarter mechanics- Segments: commercial $372M (+31% y/y, +17% q/q; ex-SPAC +37%); government $455M (+40% y/y, +11% q/q). U.S. commercial $214M (+64%/+76% ex-SPAC, +20% q/q); international commercial $158M (+3% y/y, +15% q/q — aided by an Asia revenue catch-up); U.S. government $343M (+45%, +7% q/q); international government $112M (+28% y/y, +26% q/q — U.K. healthcare and defense; NHS FDP at 87 Acute Trusts and 28 ICBs as of November 2024).
- Customer count 711, +43% y/y, +13% q/q. Top-20 customers $65M TTM each, +18% y/y — second consecutive acceleration (+9% → +12% → +18%).
- Bookings: total TCV $1.79B, +56% y/y, +63% q/q; commercial TCV $995M, +42% y/y, +63% q/q; 32 deals ≥$10M (record); total remaining deal value $5.43B, +40% y/y, +20% q/q (reaccelerating from +22%); RPO $1.73B, +39% y/y, +10% q/q. Termination-for-convenience/sub-12-month RPO caveat repeated.
- NDR 120%, +200bps q/q (118% → 120%), with the standard exclusion disclaimer and a note that NDR still doesn't capture the past year's new-customer velocity.
- SPAC/strategic contracts: $9.6M in Q4; Q1 2025 guided to $4–6M vs $24M LY; FY2025 ~0.5% of revenue.
- Margins: adjusted gross margin 83% (from 82%); adjusted OpEx $455M (+1% q/q, +14% y/y); AOI $373M (45%). Management guided to "a more significant increase in expense in 2025" (technical hires, product pipeline) while sustaining GAAP profitability.
- SBC: the prior-quarter flag materialized — $131M one-time SAR acceleration in Q4 on market-vesting achievement; Q4 SBC $282M plus $80M employer equity taxes; FY SBC $692M plus $126M taxes. GAAP operating income $11M (1%) vs 17% ex-SAR; GAAP net income $79M (10%) vs 20% ex-SAR.
- EPS: adjusted $0.14 Q4 / $0.41 FY; GAAP $0.03 Q4 ($0.07 ex-SAR) / $0.19 FY.
- Cash: CFO $460M (56%), adjusted FCF $517M (63%) — FCF > CFO quirk persists. Buyback ~2.1M shares cumulative (from ~1.8M); $936M remaining. Still token.
- Guidance math: Q1 guide implies +3.6–4.1% q/q and ~+36% y/y; FY midpoint +31% vs +29% in FY2024 — guided acceleration on a larger base. FY AOI guide implies ~41% margin vs 39% FY2024 actual.
Product and launch scorecard- AIP (~20 months): strongest commercial evidence yet — U.S. commercial TCV $803M (+134% y/y), remaining deal value +99%, customer count +73%, NDR 120%, and named dollar conversions ($67M pharmacy post-pilot, $40M telecom expansion, ~$11M insurer ACV expansion). Still missing: pricing model, paid-conversion rate, AIP revenue attribution — now eight quarters.
- Maven: adoption broadened across three MILDEPs and four combatant commands; contested logistics exercised; unclass-network use post-Helene; border/airspace drone-awareness missions; MAVEN REL for allies. No new ceiling or revenue figures disclosed this quarter.
- Warp Speed (quarter three): first named cohort — Anduril and L3Harris — with a quantified customer quote (200x supply-shortage response efficiency). This resolves the biggest prior-quarter gap (no named customers). Still no revenue, pricing, or cohort size disclosed.
- FedStart: FedRAMP High approval — a concrete, dated milestone for the software-company go-to-market wedge.
- NHS: back on the call after two silent quarters — 87 Acute Trusts and 28 ICBs signed up for the Federated Data Platform; international government +26% q/q attributed largely to U.K. work. Still no economics.
- Army Vantage extended up to four years (Army Data Platform); SOCOM expansion with first Mission Manager deployment to Special Operations Forces units.
- TITAN: not mentioned on the call — a regression after last quarter's "fully ramping" update.
Sell-side read-through- Same two institutional questioners, third quarter running: Wedbush (Ives) and BofA (Perez Mora). No other firms asked questions.
- Ives asked whether management is surprised by sales-cycle speed — a soft question that produced anecdotes, not conversion economics. Taylor: "not surprised… it's tangible"; Karp contrasted U.S. pragmatism vs Europe "reading PowerPoints of how you did tech installations in the 50s." Boot-camp conversion economics remain unquantified.
- BofA's two-parter was again the most substantive: (1) DOGE positioning — Sankar argued efficiency/meritocracy pressure on legacy integrators favors Palantir, citing D6A as the failed-incumbent archetype; (2) where investment goes to meet demand — Glazer: quality engineers over quantity, headcount growing "somewhat," visible in Q1 numbers; Sankar added that inbound partnership interest is now real ("people want to partner with us" for the first time).
- Retail questions: ontology defensibility (Sankar: longest-path moat, intermediary representation for governed AI; Karp: data-access and productization difficulty) and DeepSeek (commoditization vindication plus China-war framing).
- Unchallenged again: AIP monetization/pricing (eight quarters), the GAAP op-to-net wedge, FCF > CFO, TITAN economics (now not even mentioned), NHS economics, and the FY2025 FCF guide typo. The SAR acceleration was disclosed proactively but its forward SBC run-rate implications were not sized.
Management credibility- Beat-and-raise streak extends to eight quarters: revenue >900bps above the high end; AOI $373M vs $298–302M guide; FY2025 guided to +31% — above FY2024's actual +29% — with U.S. commercial guided to repeat ≥54% growth.
- Delivered on the biggest carried-forward risks: the U.S. government year-end hangover did not occur (+40% → +45% y/y, +7% q/q); ex-SPAC U.S. commercial reaccelerated (+59% → +76%) rather than normalizing further; Warp Speed produced named customers as demanded; NHS reappeared with adoption numbers.
- Honest-direction disclosures continue: Asia revenue catch-up flagged in international commercial; SAR acceleration quantified ($131M) and broken out of GAAP results with ex-SAR figures provided; 2025 expense ramp guided up explicitly.
- Debits: the SAR acceleration validates the prior SBC warning but also demonstrates how large equity-driven GAAP distortions can be (GAAP op margin 1% vs 45% adjusted — a 44pt gap); forward SBC quantum still undisclosed; TITAN dropped off the call entirely; Karp's rhetoric escalated again ("scare enemies and on occasion kill them," "heads cut off" revolution language); the FY FCF guide contains an apparent unit error ("$1.7 million") that should have been caught.
- Guidance credibility remains the core asset: the FY2025 guide embeds acceleration, not conservatism, and is backed by $1.79B TCV, remaining deal value +40%, RPO +39%, and NDR 120%.
What changed versus the prior quarter- Growth: total +30% → +36% (ex-SPAC +32% → +39%); U.S. commercial +54% → +64% headline, ex-SPAC +59% → +76% (reacceleration, reversing last quarter's normalization); U.S. government +40% → +45% (hangover thesis wrong); international commercial +3% y/y, −7% → +15% q/q (Asia catch-up helped; y/y still +3%); international government +13% → +28% y/y, −5% → +26% q/q (U.K.-driven).
- Bookings: total TCV +33% → +56% y/y ($1.1B → $1.79B); commercial TCV +52% → +42% y/y but dollars up ($612M → $995M); remaining deal value reaccelerated +22% → +40%; RPO +59% → +39% y/y.
- NDR 118% → 120%; top-20 +12% → +18%; customer count growth 39% → 43%.
- Margins: AOI margin 38% → 45% (record); adjusted gross margin 82% → 83%; GAAP op margin 16% → 1% (17% ex-SAR) on the $131M SAR acceleration.
- Guidance: FY revenue growth guide +26% (Q4-implied) → +31% for FY2025; U.S. commercial ≥50% → ≥54%; AOI margin guide ~39% → ~41%; FCF >$1B → $1.5–1.7B.
- Watchlist resolution vs prior packet: U.S. government durability ✓ (+45%); ex-SPAC U.S. commercial trajectory ✓ (76%, reaccelerated); 104-deal ≥$1M repeat — metric not restated; replaced by 32 deals ≥$10M (basis shifted again); SBC quantification ✓ partial ($131M one-time sized; forward run-rate not); Warp Speed named customers ✓ (Anduril, L3Harris); NHS ✓ (87 trusts/28 ICBs); AIP monetization ✗ (eighth quarter); op-to-net gap ✗ (not addressed; GAAP/adjusted gap now dominated by SAR); TITAN ✗ (silent); FCF vs CFO convergence ✗ (persists).
Bull case- Acceleration is six quarters deep and steepening: +36% on a ~$2.9B base with ex-SPAC +39%, and the FY2025 guide embeds further acceleration (+31% vs +29%) — management is guiding to faster growth, not sandbagging a deceleration.
- The two biggest bear-case items resolved positively: U.S. government grew through the year-end comp (+45%, +7% q/q), and ex-SPAC U.S. commercial reaccelerated to +76% with TCV +134% and remaining deal value +99% — bookings are running far ahead of revenue.
- Quality metrics keep compounding: NDR 120%, top-20 +18% (second straight acceleration), customer count +43%, 32 deals ≥$10M — land, expand, and deal size all moving together.
- Profitability inflected upward, not just held: 45% AOI margin (record), Rule of 81, FY2025 AOI guide implying ~41% margin alongside a guided expense ramp — the "invest and expand margin simultaneously" claim is currently being delivered.
- Warp Speed crossed from narrative to named customers (Anduril, L3Harris) with a quantified efficiency claim; FedStart's FedRAMP High approval adds a second new wedge with a dated milestone; Maven's mission scope keeps widening (logistics, border, airspace, allies).
- DOGE-style government efficiency pressure is framed — plausibly — as a tailwind against incumbent integrators rather than a threat to Palantir's programs.
Bear case- GAAP reality check: Q4 GAAP operating margin was 1% against a 45% adjusted margin — the $131M SAR acceleration shows how violently equity comp can compress GAAP results, and forward SBC run-rate remains undisclosed with the stock at elevated levels.
- The FY2025 guide, while strong, implies deceleration within the year: Q1 guide is ~+36% y/y against a FY guide of +31%, and U.S. commercial ≥54% matches FY2024's actual — the bar is now the prior year's peak performance, and comps get brutally harder each quarter.
- International commercial is still +3% y/y and needed an Asia revenue catch-up for its +15% q/q; Karp himself described Europe as "anemic" (~4% growth on 13% of revenue) with no fix in sight — the growth story remains almost entirely American.
- Bookings quality caveats persist: RPO growth decelerated (+59% → +39%) even as remaining deal value accelerated, and the termination-for-convenience caveat means much of the government backlog is softer than headline numbers suggest.
- Accounting loose ends: FCF > CFO again, buyback still token (~2.1M shares cumulative) against $692M FY SBC, the GAAP op-to-net wedge unaddressed, and an apparent unit error in the FY FCF guide ("$1.7 million") slipped through.
- TITAN disappeared from the call one quarter after "fully ramping"; the deals-metric basis shifted again (≥$1M count not restated; ≥$10M substituted); Karp's rhetoric ("kill them," "heads cut off") remains an unmitigated headline and customer-risk factor.
Next-quarter watchlist- Q1 vs $858–862M revenue and $354–358M AOI (~41% implied margin): does the guided 2025 expense ramp show up, and does margin hold near 41% as it does?
- U.S. commercial: ex-SPAC growth from 76% as AIP comps peak; whether anything like the $803M TCV quarter repeats; progress against the >$1.079B / ≥54% FY guide; customer count adds from 382.
- U.S. government: Maven revenue cadence across the new MILDEP/COCOM expansions; any DOGE-related disruption to legacy programs converting into Palantir awards; SOCOM Mission Manager follow-on.
- SBC: forward run-rate now that SAR market-vesting has triggered; whether GAAP op margin recovers toward the 17% ex-SAR level; any updated equity-comp disclosure.
- Warp Speed: cohort size beyond Anduril/L3Harris, first revenue or pricing disclosure, and whether the "swelling pipeline" converts to named additions.
- AIP monetization, eight quarters overdue: pricing, paid-conversion, or revenue attribution.
- NDR from 120%; top-20 growth holding near +18%; international commercial after the Asia catch-up laps; NHS FDP economics now that adoption numbers are public.
- TITAN: any reappearance with ramp economics or margin treatment.
- Cash: FCF vs CFO convergence; buyback pace against $936M remaining; confirmation of the FY FCF guide figure ($1.5–1.7B) after the transcript's apparent typo.
|
| Nov 4, 2024 | +23.47% | Q3 FY2024 | Read transcript briefingQuarter in one view- Revenue $726M, +30% y/y, +7% q/q — beat the high end of the $697–701M guide by ~450bps; ex-strategic-contracts +32% y/y. Fifth consecutive acceleration quarter (+17% → +20% → +21% → +27% → +30%).
- U.S. business $499M implied, +44% y/y, +14% q/q. U.S. commercial $179M, +54% y/y (+59% ex-SPAC), +13% q/q; customer count 321, +77% y/y; U.S. commercial TCV $297M, +13% q/q; remaining deal value +73% y/y. U.S. government $320M, +40% y/y, +15% q/q — strongest sequential growth in 15 quarters, DoD +21% q/q, aided by government fiscal year-end timing.
- Profitability records again: AOI $276M (38% margin, eighth straight expansion), GAAP operating income $113M (16%), GAAP net income $144M (20%), Rule of 40 at 68 (+4pts q/q). CFO $420M (58% margin), adjusted FCF $435M (60%); TTM adjusted FCF crossed $1B for the first time.
- Guidance raised across the board for the third straight quarter: FY revenue to $2.805–2.809B (from $2.742–2.750B), U.S. commercial to >$687M (≥50% growth, from ≥$672M/≥47%), AOI to $1.054–1.058B (from $966–974M), FCF to >$1B (from $0.8–1.0B). Q4: revenue $767–771M, AOI $298–302M.
- S&P 500 inclusion in September flagged repeatedly as validation.
What management is focused on- "Commoditization of cognition" as the new master frame: models are converging across open/closed source while inference pricing is "dropping like a rock" — therefore value accrues to the application/workflow layer and the ontology, where Palantir claims a decade-long head start. This is a sharpening of last quarter's "prototype to production" narrative into an explicit argument that the LLM itself is the commodity.
- Quantified production outcomes as proof standard: insurer underwriting automated with 78 AI agents, two weeks → 3 hours; Associated Materials on-time-in-full 40% → 90% across 10+ use cases in nine months; Trinity Rail functional workflow in three months with $30M bottom-line impact; Maven targeting cell 2,000 staff → ~20 (citing a Georgetown CSET study); foreign disclosure process three days → 3 hours.
- Deal velocity: 104 deals ≥$1M closed (the retired funnel metric returns at a new basis); equipment rental company expanded to 12x ARR within eight months of enterprise conversion; three seven-figure ACV deals signed <2 months post-boot camp.
- Government platform momentum: new five-year Maven Smart System contract expanding AI/ML across Army, Air Force, Space Force, Navy, Marines; Army as first MILDEP to adopt Maven; TITAN "fully ramping throughout Q3"; JADC2 SDK released publicly; DevCon announced for this month with enhanced OSDK, compute modules, multimodal data plane.
- Warp Speed repositioned toward reindustrialization-as-deterrence: Sankar's 6% → 86% prime-concentration statistic; now explicitly working with L3Harris and "two other of the big primes" plus Anduril and Shield AI — a notable expansion beyond last quarter's "new manufacturers only" wedge.
- Partner-ecosystem strategy: Karp and Taylor attribute the defense-tech partnership wave (L3Harris, Anduril, Shield AI displaying Palantir logos) to Mission Manager/Apollo/Rubix infrastructure and a deliberate effort to dispel the "Palantir wins too much" perception.
- Karp's monologue: full victory lap on the DPO-era thesis, "bring violence and death to our enemies," West/America superiority framing, and a steel-manned rejection of margin-for-growth tradeoffs ("Rule of 68… best in the world").
Key numbers and quarter mechanics- Segments: commercial $317M (+27% y/y, +3% q/q; ex-SPAC +30%); government $408M (+33% y/y, +10% q/q). U.S. commercial $179M (+54%/+59% ex-SPAC, +13% q/q); international commercial $138M (+3% y/y, −7% q/q — Europe headwinds plus a step-down from a Middle East government-sponsored enterprise); U.S. government $320M (+40%, +15% q/q); international government $89M (+13% y/y, −5% q/q — Q2 catch-up and deal timing).
- Customer count 629, +39% y/y, +6% q/q. Top-20 customers $60M TTM each, +12% y/y — first reacceleration after six quarters of deceleration/stall (+15% → … → +9% → +9% → +12%).
- SPAC/strategic contracts: $9.6M in Q3 (~1% of revenue); Q4 guided to $6–7.5M vs $20M LY; FY <2%. Glazer: "the program ended three years ago… basically not relevant anymore."
- Bookings/backlog: total TCV $1.1B, +33% y/y, +16% q/q; commercial TCV $612M, +52% y/y, +62% q/q; total remaining deal value $4.5B (+22% y/y, +4% q/q — decelerating from +26%); RPO $1.6B (+59% y/y, +15% q/q). Termination-for-convenience/sub-12-month RPO caveat repeated.
- NDR 118%, +400bps q/q (114% → 118%) — expansions plus the Q3 2023 cohort; exclusion disclaimer repeated.
- Margins: adjusted gross margin 82% (from 83%); adjusted OpEx $450M (+6% q/q, +14% y/y — ramp steepening, driven by AIP and technical talent); AOI $276M (38%). Q4 AOI guide implies ~39% margin.
- GAAP: operating income $113M (16%), net income $144M (20%). Op-to-net wedge $31M (from $29M) — still unexplained and still growing.
- EPS: adjusted $0.10 (from $0.09), GAAP $0.06 (flat q/q).
- Cash: CFO $420M (58%), adjusted FCF $435M (60%) — FCF > CFO quirk persists; cash/T-bills $4.6B (from $4.0B).
- Buyback: ~1.8M shares repurchased through Q3 (from ~1.2M through Q2); $954M remaining. Still token.
- New disclosure flag: Glazer warned SBC could accelerate if market-based vesting criteria are hit early given the stock's rise — the first time SBC quantum/timing has been proactively raised on a call, though still unquantified.
- Guidance math: FY midpoint $2.807B (+26%, from +23%); Q4 guide implies +5.6–6.2% q/q and ~+26% y/y. U.S. government +40% explicitly attributed partly to "favorable deal timing… coupled with government year-end cycle" — a disclosed one-time tailwind.
Product and launch scorecard- AIP (~17 months): strongest evidence set yet — 104 deals ≥$1M, $612M commercial TCV (+52% y/y), U.S. commercial remaining deal value +73%, NDR 118%, and multiple quantified production outcomes (underwriting 2 weeks → 3 hours; OTIF 40% → 90%; $30M Trinity Rail impact; 12x ARR expansion in 8 months). Still missing: pricing model, paid-conversion rate, AIP revenue attribution. The "deals ≥$1M" metric returned after a one-quarter substitution with deals ≥$10M — welcome, but the basis instability across quarters remains a comparability problem.
- Maven: new five-year expansion across all five military services; Army first MILDEP adoption; Georgetown CSET study cited as third-party validation of the 2,000 → 20 targeting claim. This is the follow-through on last quarter's CDAO award — the $480M ceiling is being converted into service-wide scale.
- TITAN: back on the call after a silent quarter — "efforts fully ramping throughout Q3," plus application-integrator role in the Joint Fires Network. Still no revenue-recognition cadence or margin treatment disclosed.
- Warp Speed (quarter two): positioning broadened materially — from new-manufacturer wedge to also serving L3Harris and two other big primes ("bend atoms better with bits"), framed around reindustrialization and fixed-price margin expansion for partners. Still zero customers named as Warp Speed customers, no revenue, no pricing.
- Developer platform: JADC2 SDK publicly released; 18th Airborne green-suiters built 15 apps for a warfighter exercise; 101st built a Hurricane Helene search-and-rescue COP; Army Software Factory active in Europe; DevCon scheduled this month with OSDK/compute-module/multimodal-data-plane releases. Adoption anecdotes are concrete but no developer-count or conversion metrics.
- NHS, Oracle/hyperscaler partnerships: unmentioned for the second consecutive quarter.
Sell-side read-through- Only two institutional questions again, both from the same two firms as last quarter: Wedbush (Ives) on boot-camp conversion speed, and BofA (Perez Mora) with a two-parter on why defense partners now want Palantir and on strategic-contract remaining deal value (Lilium, stock-as-payment).
- Ives's question produced no new data — Glazer restated headline growth and the <2-month boot-camp-to-seven-figure examples; Karp offered churn-of-personnel network effects ("five people go to a different company, the first thing they do is pick up the phone"). The conversion-economics question remains unanswered in quantified form.
- BofA's question was again the most substantive: it extracted the clearest account of the partner-ecosystem strategy (Mission Manager/Apollo as accelerants; Karp's candid "Palantir wins too much" friction diagnosis; helping primes expand margin on fixed-price work). The strategic-contracts half was effectively closed as a topic — "basically not relevant anymore" — though the Lilium/stock-payment part of the question was not directly addressed.
- Retail questions on AI differentiation drew the ontology/convergence answer; the margin-balance question drew Karp's steel-man "Rule of 68 is best in the world, we won't trade it for growth" response — a clear statement of capital-allocation intent.
- Unchallenged again: AIP monetization/pricing (seven quarters), SBC dollar quantum (now flagged but not sized), the $31M GAAP op-to-net gap, FCF > CFO, the revolver, TITAN economics, NHS economics, and the U.S. government year-end timing benefit embedded in the +40% print. Q&A remains narrative reinforcement.
Management credibility- Beat-and-raise streak extends to seven quarters: revenue ~450bps above the high end, AOI $276M vs $233–237M guide, FY raised on all lines (revenue, U.S. commercial, AOI, FCF) for the third consecutive quarter.
- Delivered on the biggest carried-forward items: U.S. government reacceleration not only held but nearly doubled again (+24% → +40%), top-20 growth finally inflected (+9% → +12%), NDR kept climbing (114% → 118%), and the Maven five-year service-wide expansion converts last quarter's award into visible follow-through.
- Honest-direction disclosures: management itself flagged the government year-end timing benefit in the +40% print, the international government Q2 catch-up, the Middle East GSE step-down, and the potential SBC acceleration — all voluntary, all unfavorable-neutral.
- Debits persist: op-to-net gap widened to $31M unexplained; funnel metric basis shifted again (≥$1M restored after a quarter of ≥$10M headlines); Warp Speed's target-customer story changed within one quarter (new manufacturers only → also three big primes) without acknowledging the shift; TITAN economics still undisclosed; Karp's rhetoric escalated further ("violence and death to our enemies," "bad shit crazy" self-reference).
- Guidance credibility remains the strongest asset: raises are backed by $1.1B TCV, RPO +59%, NDR 118%, and a Q4 AOI guide implying ~39% margin — the under-promise/over-deliver pattern is intact and now extends to cash flow (>$1B FCF guide).
What changed versus the prior quarter- Growth: total +27% → +30% (ex-SPAC +30% → +32%); U.S. commercial +55% → +54% headline but ex-SPAC +70% → +59% (first normalization, still extreme); U.S. government +24% → +40% (with disclosed year-end timing help); international commercial +15% → +3% y/y, −1% → −7% q/q (materially worse — Europe plus Middle East GSE step-down); international government +21% → +13% y/y, +18% → −5% q/q (last quarter's Eastern Europe driver did not repeat).
- Bookings: total TCV +47% → +33% y/y but dollars up ($946M → $1.1B); commercial TCV accelerated +31% → +52%. Remaining deal value growth decelerated +26% → +22%.
- NDR 114% → 118%; top-20 +9% → +12% (inflection); customer count growth 41% → 39%.
- Guidance: FY midpoint +23% → +26%; U.S. commercial ≥47% → ≥50%; AOI midpoint ~$1.056B (~37.6% margin, from ~35.3%); FCF >$1B (from $0.8–1.0B).
- SBC: first-ever proactive flag of potential acceleration on market-based vesting — a new watch item management put on the table itself.
- Watchlist resolution vs prior packet: U.S. government durability ✓ (+40%); Maven follow-on ✓ (five-year service-wide expansion); TITAN update ✓ partial (ramping, no economics); deals ≥$1M metric ✓ restored (104); ex-SPAC U.S. commercial near 70% ✗ (59% — first real normalization); AIP monetization ✗ (seventh quarter); SBC quantum ✗ (flagged, not sized); op-to-net gap ✗ (worsened to $31M); Europe ✗ (worse, −7% q/q); NHS ✗ (silent again); Warp Speed customers ✗ (none named).
Bull case- Acceleration is now five quarters deep and broadening: +30% headline with U.S. +44% on a ~$2B base, U.S. government at a 15-quarter sequential high, and commercial TCV +52% y/y — bookings are confirming the revenue, not borrowing from it.
- The quality metrics inflected the right way for the first time: top-20 growth broke its stall (+9% → +12%), NDR hit 118%, RPO +59%, and the 104-deal ≥$1M print shows the funnel widening at the same time deal sizes grow — land and expand are compounding simultaneously.
- Maven is converting from award to platform reality: five-year, all-five-services expansion, Army MILDEP adoption, third-party academic validation, and a public JADC2 SDK — the DoD-substrate thesis now has contractual and ecosystem evidence.
- Cash generation stepped up hard: $420M CFO / $435M FCF in one quarter, TTM FCF >$1B, FY FCF guide raised to >$1B, and Q4 AOI guide implies ~39% margin — the Rule of 68 print with a stated commitment (Karp's steel-man answer) not to sacrifice it for growth.
- Warp Speed's aperture widened from startups to three of the big primes plus Anduril/Shield AI — if the reindustrialization framing lands, the TAM argument strengthened even before revenue appears.
Bear case- The +40% U.S. government print carries disclosed one-time help (fiscal year-end timing); international government already showed how fast these drivers reverse (+18% q/q → −5% q/q in one quarter). Q4 U.S. government comparability is at risk of a hangover.
- Ex-SPAC U.S. commercial decelerated for the first time in the AIP era (+70% → +59%) — still exceptional, but the toughest comps are only now arriving, and the FY ≥50% guide embeds continued deceleration.
- International is deteriorating, not stabilizing: international commercial +3% y/y, −7% q/q with a named Middle East GSE step-down on top of Europe; the growth story is now almost entirely American, and remaining-deal-value growth decelerated to +22%.
- SBC acceleration is now a guided risk, not just an analyst complaint — market-based vesting could pull expense forward precisely as the stock re-rates, and the dollar quantum remains undisclosed.
- Accounting loose ends keep growing: op-to-net wedge $31M and unexplained, FCF > CFO again, buyback still token (~1.8M shares) against dilution, and TITAN's hardware economics remain undisclosed while it "ramps."
- Warp Speed's customer framing changed within a quarter without acknowledgment — a small but real narrative-discipline issue; Karp's rhetoric ("violence and death," commune jokes) remains an unmitigated headline risk.
Next-quarter watchlist- Q4 vs $767–771M revenue and $298–302M AOI (~39% implied margin): does the expense ramp coexist with margin expansion as guided, and does revenue hold ~+26% y/y with SPAC down to $6–7.5M vs $20M LY?
- U.S. government: how much of the +40% was year-end pull-forward — watch the Q4/Q1 sequential pattern; Maven service-expansion revenue cadence against the $480M ceiling; TITAN ramp economics and margin treatment.
- U.S. commercial: ex-SPAC growth trajectory from 59% as AIP-era comps peak; whether the 104-deal ≥$1M count repeats; U.S. commercial TCV ($297M) and remaining deal value (+73%) momentum against the ≥50% FY guide.
- SBC: first quantification and whether market-based vesting acceleration materializes; impact on GAAP margins and the op-to-net wedge ($31M).
- Warp Speed: first named customers, revenue, or pricing; whether prime engagement (L3Harris + two others) produces disclosed contracts; DevCon output (enhanced OSDK, compute modules, multimodal data plane) and any developer-adoption metrics.
- AIP monetization, seven quarters overdue: pricing, paid-conversion, or revenue attribution.
- NDR from 118%; top-20 growth holding above +12%; international commercial stabilization after the −7% q/q and Middle East GSE step-down; any NHS or Oracle/hyperscaler mention after two silent quarters.
- Cash: FCF vs CFO convergence; buyback pace against the $954M remaining authorization; cash balance trajectory from $4.6B.
|
Corbanu